Study of macromolecular interactions using computational solvent mapping by Tang, Jisi
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2014
Study of macromolecular
interactions using computational
solvent mapping
https://hdl.handle.net/2144/15100
Boston University
BOSTON UNIVERSITY 
 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
AND 
 
COLLEGE OF ENGINEERING 
 
 
 
 
Dissertation 
 
 
 
 
STUDY OF MACROMOLECULAR INTERACTIONS USING  
 
COMPUTATIONAL SOLVENT MAPPING 
 
 
 
 
by 
 
 
 
 
JISI TANG 
 
B.S., Shanghai Jiao Tong University, 2009 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Doctor of Philosophy 
 
2014  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 by 
 JISI TANG 
 All rights reserved  

	   iv 
ACKNOWLEDGMENTS 
I would like to thank everyone in the Structural Bioinformatics Lab for their help in the 
past few years. I would particularly like to thank: Sandor Vajda and Dima Kozakov, for 
providing large amounts of help in guiding my research, and being exceptionally flexible 
in my PhD career. I thank Dmitri Beglov, David Hall, Chi Ho Ngan and Brandon Zerbe 
for hands-on instructions on valuable techniques and experiences that I have used every 
day in my research work. I thank the Bioinformatics program for accepting me into the 
program, and having granted travel scholarships to enable me to present my work in 
conferences. I also would like to thank my Dad, Mom, and my brother Almas, for your 
years of love and sacrifices for me to finish my prolonged education. At last, I thank my 
wife, Cao Yuhua: without your love and support I couldn’t have concentrated so much on 
my research work. 
  
	   v 
STUDY OF MACROMOLECULAR INTERACTIONS USING 
COMPUTATIONAL SOLVENT MAPPING 
JISI TANG 
(Also known as, TANGGIS BOHNUUD) 
Boston University Graduate School of Arts and Sciences and 
College of Engineering, 2014 
Major Professor: Sandor Vajda, Professor of Biomedical Engineering 
 
ABSTRACT 
The term “binding hot spots” refers to regions of a protein surface with large 
contributions to the binding free energy.  Computational solvent mapping serves as an 
analog to the major experimental techniques developed for the identification of such hot 
spots using X-ray and nuclear magnetic resonance (NMR) methods.  Applications of the 
fast Fourier-transform-based mapping algorithm FTMap show that similar binding hot 
spots also occur in DNA molecules and interact with small molecules that bind to DNA 
with high affinity.  Solvent mapping results on B-DNA, with or without Hoogsteen (HG) 
base pairing, have revealed the significance of “HG breathing” on the reactivity of DNA 
with formaldehyde.  Extending the method to RNA molecules, I applied the FTMap 
algorithm to flexible structures of HIV-1 transactivation response element (TAR) RNA 
and Tau exon 10 RNA.  Results show that despite the extremely flexible nature of these 
small RNA molecules, nucleic acid bases that interact with ligands consistently have high 
hit rates, and thus binding sites can be successfully identified.  Based on this experience 
as well as the prior work on DNA, I extended the FTMap algorithm to mapping nucleic 
	   vi 
acids and implemented it in an automated online server available to the research 
community.  FTSite, a related server for finding binding sites of proteins, was also 
extended to develop PeptiMap, an accurate and robust protocol that can determine 
peptide binding sites on proteins.  Analyses of structural ensembles of ligand-free 
proteins using solvent mapping have shown that such ensembles contain pre-existing 
binding hot spots, and that such hot spots can be identified without any a priori 
knowledge of the ligand-bound structure.  Furthermore, the structures in the ensemble 
having the highest binding-site hit rate are closest to the ligand-bound structure, and a 
higher hit rate implies improved structural similarity between the unbound protein and its 
bound state, resulting in high correlation coefficient between the two measures.  These 
advances should greatly enhance researchers’ ability to identify functionally important 
interactions among biomolecules in silico. 
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CHAPTER 1 Background and introduction 
1.1 Molecular interactions in biological activities 
Interactions between molecules are important for their tremendous roles in biological 
activities. Intermolecular recognition and reactions between proteins or peptides, DNA, 
RNA, and small molecules are responsible for enzymatic reactions, signal transductions 
and various regulations involved in the cells. Most of the rational drug development 
efforts aim to disrupt the natural interactions occurring in the biological systems, 
examples of which include the inhibition of enzyme-substrate interactions, using 
competitors or allosteric effect; antibiotics that disruption of the unique and crucial 
interactions that occur in pathogens; and anticancer drugs that target up-regulated 
interactions in tumor cells. With the emerging interest in developing agents that target 
nucleic acids, I discussed molecular interactions involving DNA and RNA in Chapters 2 
and 3. 
While important models have been developed and relatively successful in assuming the 
rigid structures, examples have shown that the flexibility of molecules should not be 
ignored. Some molecules exist in such dynamic ensemble that it is impossible to obtain a 
stable structure. The aforementioned RNA molecule HIV TAR to be described in Chapter 
2 is such a case, where the dynamic structures in NMR are the only available material. In 
Chapter 5 I describe an interesting insight into the behavior of such naturally occurring 
structural ensembles observed using the computation solvent mapping method. 
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1.2 Introduction to computational solvent mapping 
Computational solvent mapping is a method originally developed for identification and 
characterization of binding hot spots on proteins, i.e., smaller regions of the binding site 
that are major contributors to the binding free energy (Brenke, et al., 2009). It was shown 
earlier by X-ray crystallography (Mattos and Ringe, 1996) and NMR (Liepinsh and 
Otting, 1997) that in proteins the hot spots bind small organic molecules of various sizes 
and shapes, and that the number of bound “probe” molecules predicts the potential 
importance of the site for ligand binding. We have developed the FTMap algorithm to 
identify such probe binding sites computationally (Brenke, et al., 2009).  
I applied the FTMap method to DNA (Chapter 2), RNA (Chapter 3), and on proteins for 
peptide binding site (Chapter 4). It is interesting to note that the concept of druggable hot 
spots occur in all these major bio-macromolecules. The beauty of this study is that the 
general methods are applied to all the subjects, although detailed modifications and 
specific techniques of data analyses are utilized in each study. Following is the general 
method that has been developed and tested by generations of members of the lab. 
Specific details are again described in each chapter’s method section, if necessary. 
 
1.3 Methods 
FTMap samples probe-protein interactions on a dense grid, finds favorable positions 
using empirical energy functions, clusters the conformations, and ranks the clusters on 
the basis of the average energy. For each probe, six bound probe clusters with the lowest 
mean interaction energies are retained. The clusters from the different probe types are 
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then clustered into consensus clusters. The positions of the consensus clusters, termed 
consensus sites (CSs), define the binding hot spots where multiple probe molecules bind, 
identifying the regions most likely to bind small ligands.  The CSs are ranked on the basis 
of the number of probe clusters they incorporate. The largest CSs represent the most 
important hot spots, in good agreement with the results of screening libraries of small 
molecules using X-ray crystallography (Mattos and Ringe, 1996) or NMR (Liepinsh and 
Otting, 1997) for detection. 
 
1.4 Contributions 
The work in Chapter 2 was performed with Dmitri Beglov who developed non-linear 
Poisson-Boltzmann equation based electrostatic potential, which I then tested and 
parameterized to suit the mapping of DNA, and later the RNA (Chapter 3). Chi Ho Ngan 
created force-field parameters for formaldehyde molecule which I used as a probe in 
mapping DNA. The work in Chapter 4 was initiated by Chi Ho Ngan in collaboration 
with the Ora Schuler-Furman, but I contributed to the protocol in separating the domains, 
treating multimers and inner sites, and training the protocol and testing it on the 
validation set. 
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CHAPTER 2 Mapping DNA 
2.1 Introduction 
Although formaldehyde has long been considered as a chemical hazard capable of 
damaging DNA, only in recent years it has been realized that formaldehyde forms 
endogenously within the cell nucleus.  It has been established that a process of histone 
demethylation by recently discovered histone demethylation enzymes inevitably leads to 
the accumulation of formaldehyde within the cell nucleus, in direct vicinity of DNA 
(reviewed in (Mosammaparast and Shi, 2010)). This may lead to the extensive DNA 
damage.  Most recently, the lethal consequences of the endogenous formaldehyde 
accumulation in the cell nucleus have been experimentally demonstrated for cells 
deficient in both the formaldehyde digesting enzyme ADH5 and the enzyme that repairs 
DNA damages inflicted by formaldehyde (Rosado, Langevin, Crossan, Takata and Patel, 
2011). These findings put into the forefront the issue of DNA reactivity with 
formaldehyde and constitute a major motivation of the present work.  
Our focus here is not the well-known effect of DNA crosslinking by formaldehyde, 
which is a very important but very rare event, but the formaldehyde’s chemical reaction 
with amino and imino groups of DNA bases. Previous attempts to fully understand the 
reactivity of duplex DNA with respect to formaldehyde on the basis of extensive 
experimental and theoretical studies (Lazurkin, Frank-Kamenetskii and Trifonov, 1970, 
Utiyama and Doty, 1971, McGhee and von Hippel, 1975, McGhee and von Hippel, 1975, 
Lukashin, Vologodskii, Frank-Kamenetskii and Lyubchenko, 1976, Frank-Kamenetskii, 
1983, Frank-Kamenetskii, 1985, Frank-Kamenetskii, 1987) left a pivotal question 
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unanswered. Although it was convincingly shown that fluctuational openings of base 
pairs play an important role in the process, there was also a strong indication that a major 
reaction, hydoxymethylation of the cytosine amino group, proceeds without full base pair 
openings (Frank-Kamenetskii, 1983, Frank-Kamenetskii, 1985).  Does it mean that 
formaldehyde attacks the cytosine amino group directly at the bottom of the B-DNA 
major groove? This issue could not be resolved before. Here we address this question 
computationally.  
The main tool of our analysis is computational solvent mapping, a method originally 
developed for identification and characterization of binding hot spots on proteins, i.e., 
smaller regions of the binding site that are major contributors to the binding free energy 
(Brenke, et al., 2009). It was shown earlier by X-ray crystallography (Mattos and Ringe, 
1996) and NMR (Liepinsh and Otting, 1997) that in proteins the hot spots bind small 
organic molecules of various sizes and shapes, and that the number of bound “probe” 
molecules predicts the potential importance of the site for ligand binding. We have 
developed the FTMap algorithm to identify such probe binding sites computationally 
(Brenke, et al., 2009). FTMap samples probe-protein interactions on a dense grid, finds 
favorable positions using empirical energy functions, clusters the conformations, and 
ranks the clusters on the basis of the average energy. For each probe, six bound probe 
clusters with the lowest mean interaction energies are retained. The clusters from the 
different probe types are then clustered into consensus clusters. The positions of the 
consensus clusters, termed consensus sites (CSs), define the binding hot spots where 
multiple probe molecules bind, identifying the regions most likely to bind small ligands.  
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The CSs are ranked on the basis of the number of probe clusters they incorporate. The 
largest CSs represent the most important hot spots, in good agreement with the results of 
screening libraries of small molecules using X-ray crystallography (Mattos and Ringe, 
1996) or NMR (Liepinsh and Otting, 1997) for detection. 
In addition to exploring computationally the B-DNA reactivity with respect to 
formaldehyde, we also check how the reactivity can be affected by a recently found new 
mode of the DNA double helix breathing (Nikolova, et al., 2011), which was overlooked 
before (see commentaries (Honig and Rohs, 2011, Frank-Kamenetskii, 2011)).  
According to these new data, classical Watson-Crick (WC) base pairs spontaneously flip 
into unusual Hoogsteen (HG) pairs under most normal ambient conditions (Figure 2.1). 
The probability of WC-to-HG transition proved to be about three orders of magnitude 
higher than that of the previously extensively studied breathing mode of DNA consisting 
in base pair opening, which occurs with the probability of about 10-5 (Frank-Kamenetskii, 
1987, Nikolova, et al., 2011, Frank-Kamenetskii, 2011, Gueron, Kochoyan and Leroy, 
1987, Krueger, Protozanova and Frank-Kamenetskii, 2006).  Previously, flipping of WC 
pairs into HG pairs was demonstrated by X-ray crystallography within some DNA-
protein complexes, most notably in case of p53 binding to DNA (Kitayner, et al., 2010). 
The HG pair is expected to inflict much milder violation on the canonical DNA structure 
than base pair openings. Still, although stacking interaction between the HG pair and 
adjacent WC pairs is preserved (see Figure 2.1B), the shorter distances between 
glycosidic bonds in HG pairs may entail a significant perturbation in the regular structure 
of the canonical all-WC double helix (B-DNA). 
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Figure 2.1 Hoogsteen base pairs. (A) Hoogsteen (HG) AT and GC+ base pairs between antiparallel DNA strands. 
Note that purines in both pairs must assume the unusual syn conformation.  Hydrogen bonds are shown as dashed lines. 
(B) Incorporation of HG pairs into the regular double helix.  Only HG pairs (light gray) and two adjacent WC pairs 
(dark gray) are shown.  HG pairs are nicely stacked with neighboring WC pairs. 
In this work we describe an extension of the FTMap algorithm (Brenke, et al., 2009) to 
nucleic acids and determine the binding hot spots of DNA structures with WC and HG 
base pairs. In contrast to proteins, no experimentally determined hot spots are known for 
DNA structures, but our results agree well with the binding sites of drug-like molecules 
in the minor groove. In addition to the hot spots in the minor groove, the mapping also 
reveals a hot spot in the major groove close to the amino nitrogen atom of cytosines. 
Once the existence of a hot spot in the major groove was established, we focused on the 
number and orientation of carbonyl groups from various probes near the amino nitrogen 
atom of cytosine, and also performed mapping calculations using formaldehyde as the 
additional probe.  
Our results show that in case of B-DNA the cytosine amino groups must be totally 
inaccessible for formaldehyde reaction. HG pairing increases the accessibility of amino 
groups of cytosines, participating in WC pairing adjacent to HG pairs, to small 
molecules, changes the local binding properties of the DNA, and dramatically increases 
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the exposure of the amino groups to formaldehyde reaction. In case of regular B-DNA 
with only WC pairs, no clustering of formaldehyde molecules in the vicinity of cytosine 
amino groups is observed.  By contrast, the incorporation of an HG pair into B-DNA 
results in very substantial clustering of formaldehyde molecules in close vicinity of the 
amino group nitrogen of a cytosine participating in WC pairing but adjacent to the HG 
pairs.  A substantial portion of the formaldehyde molecules in the cluster has orientation 
favorable for chemical attack leading to hydroximethylation of the amino group.  Our 
results indicate that some aspects of DNA reaction with formaldehyde, which have 
remained a mystery over the past 25 years, may be explained on the basis of recently 
discovered HG breathings of base pairs (Nikolova, et al., 2011).  
 
2.2 Methods 
2.2.1 Comutational solvent mapping 
The FTMap algorithm (Brenke, et al., 2009) was extended for application to nucleic 
acids, and is available as a beta version at http://ftmap.bu.edu/beta. The algorithm 
includes five computational steps as follows. 
Step 1: Soft rigid body docking of probe molecules. DNA structures were downloaded 
from the Protein Data Bank (Berman, et al., 2000). All bound ligands, ions, and water 
molecules were removed. We used 16 small molecules as probes (ethanol, isopropanol, 
tert-butanol, acetone, acetaldehyde, dimethyl ether, cyclohexane, ethane, acetonitrile, 
urea, methylamine, phenol, benzaldehyde, benzene, acetamide, and N, N-
dimethylformamide). For each probe, millions of docked conformations were sampled by 
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soft rigid body docking based on Fast Fourier Transform (FFT) correlation approach 
(Brenke, et al., 2009). The method performs exhaustive evaluation of an energy function 
in the discretized 6D space of mutual orientations of the protein (receptor) and a small 
molecular probe (ligand). The center of mass of the DNA was fixed at the origin of the 
coordinate system. The translational space was represented as a grid of 0.8 Å 
displacements of the probe center of mass, and the rotational space is quasi-uniformly 
sampled using 500 rotations of the probe (Brenke, et al., 2009). The energy expression 
includes a stepwise approximation of the van der Waals energy with attractive and 
repulsive contributions, a hydrogen bonding term and an electrostatics/solvation term 
based on nonlinear Poisson-Boltzmann continuum calculation. The values of the potential 
were smoothly interpolated up to the first derivative using a tricubic interpolation 
algorithm.  
Step 2: Minimization and rescoring. For each probe type the 2000 lowest energy DNA-
probe complexes, generated in Step 1, were refined by off-grid energy minimization 
during which the DNA atoms are held fixed whereas the atoms of the probe molecules 
are free to move. The energy function includes the bonded and van der Waals terms of 
CHARMM force field (Brooks, et al., 2009)  and an electrostatic interaction term using 
the Poisson-Boltzmann potential generated in Step 1.  
Step 3: Clustering and ranking. The minimized probe conformations from Step 2 are 
grouped into clusters using a simple greedy algorithm. The lowest energy structure is 
selected and the structures within 4 Å RMSD are joined in the first cluster. The members 
of this cluster are removed, and the next lowest energy structure is selected to start the 
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second cluster. This step is repeated until the entire set is exhausted. Clusters with less 
than 10 members are excluded from consideration. The retained clusters are ranked by 
their Boltzmann averaged energies. Six clusters with the lowest average free energies are 
retained for each probe. 
Step 4: Determination of consensus clusters. To determine consensus sites, i.e., regions 
on the DNA where clusters of different probes overlap, the probe cluster centers are 
clustered using the distance between their centers of mass with a 4 Å clustering radius. 
The resulting consensus clusters are ranked based on the number of their clusters. 
Duplicate clusters of the same type are considered in the count. 
Step 5: Functional clustering of CO groups. To determine the regions favorable for 
interactions with the carbonyl group, we applied the clustering algorithm described in 
Step 3 to the CO groups of all acetone, acetaldehyde, acetamide, and urea probes in the 
consensus site located in the major groove. 
2.2.2 Docking assisted by functional clustering 
The initial docking was carried out using the FTMap algorithm, simply considering 
formaldehyde as an additional probe (acetaldehyde was already in our original probe set). 
The formaldehyde positions were clustered and ranked on the basis of their Boltzmann 
averaged energies, and six clusters with the lowest average energy were retained. The 
formaldehyde cluster overlapping with the highest population cluster of CO groups was 
selected as the most likely region with preference for formaldehyde binding and the 
lowest energy formaldehyde pose within the cluster was used to represent the most likely 
bound position.  
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2.3 Results 
2.3.1 Identification of the binding hot spots in B-DNA 
While the existence of binding hot spots has been well established for proteins both 
experimentally (Mattos and Ringe, 1996, Liepinsh and Otting, 1997) and computationally 
(Brenke, et al., 2009), no such analyses have been performed for DNA. To see whether 
similar hot spots exist in DNA, we have mapped a ligand-free B-DNA structure of 
d(CGCGAATTCGCG)2 (PDB code 1BNA) because both unbound and ligand-bound 
structures  are available for this sequence. Figure 2.2A shows the main hot spot from 
mapping, defined by the largest consensus site, CS1, which includes 23 probe clusters 
(shown in cyan, in mesh representation). In addition to the main hot spot, Figure 2.2A 
also shows the drug distamycin A bound in the minor groove of B-DNA (PDB code 
267D). Figure 2.2B shows the nine largest consensus sites that bind probe clusters 
ranging from 23 in CS1 to 10 in CS9. Consensus sites CS1 (cyan), CS3 (18 probes 
clusters, yellow) and CS5 (15 probe clusters, purple) overlap the site that binds a variety 
of drugs. Sites CS2 (20 clusters), CS4 (16 clusters), CS6 (14 clusters), CS7 and CS8 
(both 12 clusters) are also in the minor groove, extending the major drug binding site on 
both sides, and are all shown colored in wheat. Finally, CS9 (with 10 probe clusters, 
shown in blue) is located in the major groove. Figure 2.2C is a close-up of consensus 
sites CS1, CS3, and CS5 in the minor groove, and shows the overlap of these hot spots 
with three drugs (distamycin A, netropsin and diamidine) bound to DNA. That the main 
hot spot and the nearby substantial hot spots identified in unbound DNA structures are in 
the preferred drug binding site supports the hypothesis that the concept of binding hot 
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spots as sites mostly contributing to the binding free energy is transferable to nucleic 
acids. We note that, based on mapping with 16 different types of probe molecules, a 
druggable site on a protein comprises a hot spot binding at least 16 probe clusters and one 
or two adjacent hot spots within reach of a drug-sized molecule (Kozakov, et al., 2011).  
The site in the minor groove clearly satisfies these conditions, in agreement with its 
ability to bind drugs with high affinity. In this paper in relation to formaldehyde 
reactivity we focus on a weaker hot spot, i.e., CS9 in the major groove. 
	  
Figure 2.2 Mapping of ligand-free B-DNA (PDB code 1BNA). (A) The largest consensus site CS1 (with 23 probe 
clusters, shown as cyan mesh) overlaps with a fragment of the drug distamycin A (shown as sticks in green) in the 
minor groove. (B) Consensus sites CS1 (cyan), CS3 (yellow), and CS5 (purple) cover the entire drug binding site. 
Consensus sites CS2, CS4, and CS6-CS8 (all shown in wheat) extend the site in both directions. Consensus site C9 
(with 10 probe clusters, shown in blue), is the largest hot spot located in the major groove. (C) Close-up of consensus 
sites CS1, CS3, and CS5, overlapping the bound structures of three drugs shown as sticks. The names and color codes 
of the drugs and the PDB codes of the structures are as follows: distamycin A, green, 267D; netropsin, salmon, 101D; 
and diamidine, blue, 1VZK.  
 
2.3.2 Influence of Hoogsteen pairing on surface accessibility of the cytosine amino group 
Al-Hashimi and coworkers (Nikolova, et al., 2011) observed transient sequence-specific 
excursions away from Watson–Crick base-pairing at CA steps inside canonical duplex 
DNA towards low-populated, short-lived Hoogsteen base pairs. As will be described in 
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the Discussion section, reaction with the cytosine amino group is of primary interest for 
exploring possible effects of HG pairing on formaldehyde reaction with DNA. Increased 
reactivity most likely requires increased surface accessibility (SA) of the cytosine’s 
amino nitrogen. We have calculated the accessible surface area of the nitrogen for all 
possible triplets of bases that include the CA step. For these calculations we have built 
structures with CA in the center based on structure of the double-stranded nonamer 5’-
ATGTAAHTTC-3’ (PDB code 1K61, chain E), where the subscript H indicates 
Hoogsteen pairing. In Table 2.1 we underline the cytosine considered in the accessibility 
calculation. Results show that the accessibility of the amino nitrogen increases when C is 
at the 5’ side of a Hoogsteen A•T. Furthermore, the SA of the amino nitrogen reaches its 
maximum when a purine (A or G) is at the 5’ side of the cytosine. Since Hoogsteen 
pairing most significantly increases surface accessibility of the cytosine’s amino nitrogen 
in the triplets GCAH and ACAH, we created structures including these triplets in both WC 
and HG conformations for mapping and docking studies. 
 
Table 2.1Surface accessibility of C-N4 atom in DNA structures with HG and WC pairing 
Sequencea,b 
SA of C-N4 (Å2) 
HG WC HG-WC 
GCAH 19.71 14.93   4.78 
ACAH 19.38 15.05   4.32 
CCAH 15.60 12.27   3.33 
TCAH 14.50 8.59   5.90 
TCHA 7.63 8.46  -0.83 
ACHA 12.39 11.75   0.63 
GCHA 12.24 11.63   0.61 
CCHA 9.92 9.23   0.69 
CCHA 14.87 16.51  -1.63 
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a Subscript H indicates base with HG pairing. 
b SA is calculated for C underlined. 
Abbreviations: SA, surface accessibility; C-N4: atom N4 of Cytosine; HG/WC: 
Hoogsteen/Watson-Crick pairing for marked base; HG-WC: difference in SA from switching WC 
to HG pairing. 
 
2.3.3 Mapping of DNA structures containing ACA or GCA triplets with HG or WC 
pairing 
Mapping results for HG and WC CA pairs are similar for the minor groove, but 
qualitatively different in the major groove. Flipping to HG pairing does not affect the 
largest consensus cluster, which remains in the minor groove (Figure 2.2). Here we focus 
on consensus site CS9 in the major groove. As shown in the left panels of Figure 2.3, 
there are consensus clusters near the cytosine’s amino nitrogen atom with both HG pairs 
(Figure 2.3A) and WC pairs (Figure 2.3C). Although these figures show only the lowest 
energy structures for each cluster of the bound probes, even visual inspection reveals that 
the probes, and particularly their polar functional groups, shift toward the amino nitrogen 
atom (shown as a blue sphere) in the HG structure (Figure 2.3A). This difference is 
clearly seen in Figure 2.3E, which shows the number of probes in spherical intervals 
around the nitrogen atom. For the HG pair, maximum probe density occurs at 3.6 Å from 
the nitrogen atom, whereas for the WC pair the maximum shifts to 4.4 Å. Thus, for the 
Hoogsteen pair the entire consensus cluster shifts by about 1 Å toward the reactive group. 
The number of probe clusters in the consensus clusters also changes, albeit less visibly 
than the probe density: we observe 15 probe clusters for HG and only 13 for WC pairing. 
Thus, we conclude that HG pairing not only increases the solvent accessibility of the 
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cytosine amino group, but also creates a more preferential site for the binding of small 
molecules.  
	  
Figure 2.3 Consensus clusters of 16 probes and clustering of carbonyl group around the amino nitrogen of 
cytosine of DNA with an ACA triplet. The blue sphere indicates the cytosine’s amino nitrogen atom. For each probe 
cluster, only one representative probe pose is shown. (A) Consensus cluster of all probes in the major grove of DNA 
with HG pairing. (B) Carbonyl moiety closest to the geometric center of the cluster formed by all CO groups in probes 
acetone, acetaldehyde, acetamide, and urea for DNA with HG pairing (C) Consensus cluster in the major grove of 
DNA with WC pairing. (D) Carbonyl moiety closest to the geometric center of the cluster formed by all CO groups for 
DNA with WC pairing. (E) Number of probe atoms in spherical intervals around the amino nitrogen atom. (F) Number 
of CO groups in spherical intervals around the amino nitrogen atom. 
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Since we are specifically interested in the formaldehyde reaction, we selected the probes 
with a carbonyl functional group to see whether there is a strong pattern of the carbonyl 
(CO) moiety binding in the vicinity of the amino nitrogen. Among the probes clustering 
in this region four molecules contained a CO moiety (acetone, acetaldehyde, acetamide, 
and urea).  We have selected these probes contained in the consensus cluster in the major 
groove, and clustered the positions of their carbonyl groups using a 1.5 Å clustering 
radius (see Methods). Figures 2.3B and 2.3D show the CO group closest to the geometric 
center of the highest population cluster formed by the CO groups for HG and WC pairing 
respectively. As with total probe density, the CO distribution shifts toward the amino 
nitrogen atom in the structure with HG pairing. Figure 2.3F shows the number of CO 
groups in spherical intervals around the amino nitrogen atom for both HG and WC 
pairings. For the HG pairing the CO groups form a compact cluster at 3.6 Å from the 
nitrogen atom. In contrast, for DNA with WC pairing the density distribution is very 
diffuse, with a minor peak at 4.4 Å, but a large fraction of probes with CO groups is more 
than 5 Å away from the amino nitrogen. The same statistics have also been calculated for 
a structure with the GCA triplet (Figure 2.4 and 2.5). The results are qualitatively similar 
to the ones for the ACA triplet. For HG pairing both the peak probe density and peak CO 
group density are at 3.6 Å, about 0.8 Å closer to the amino nitrogen atom than for WC 
pairing. The maximum values of both the probe and the CO group density for GCA 
triplet with the HG pairing are slightly lower than the corresponding values observed in 
DNA with an ACA triplet. Thus, the transition to HG pairing provides better access for 
small molecules to the cytosine amino nitrogen atom in DNA with an ACA triplet than in 
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a DNA with GCA triplet, but changing from WC to HG pairing has a strong effect in 
both cases. 
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Figure 2.4 Consensus clustering of carbonyl group around the amino nitrogen of cytosine of DNA with a GCA 
triplet. The blue sphere indicates the cytosine’s amino nitrogen atom. For each probe cluster, only one representative 
probe pose is shown. (A) Consensus cluster of all probes in the major grove of DNA with HG pairing. (B) Carbonyl 
moiety closest to the geometric center of the cluster formed by all CO groups for DNA with HG pairing (C) Consensus 
cluster in the major grove of DNA with WC pairing. (D) Carbonyl moiety closest to the geometric center of the cluster 
formed by all CO groups for DNA with WC pairing. (E) Number of probe atoms in spherical intervals around the 
amino nitrogen atom. (F) Number of CO groups in spherical intervals around the amino nitrogen atom. 
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Figure 2.5 Formaldehyde binding near the amino nitrogen atom of cytosine. (A) Lowest energy formaldehyde 
pose (stick model), overlapping the highest population cluster of CO groups (shown in mesh representation) 
for the GCA triplet with HG pairing. (B) Lowest energy formaldehyde pose (stick model), overlapping the 
highest population cluster of CO groups (shown in mesh representation) for the GCA triplet with WC pairing. 
 
2.3.4 Distribution of formaldehyde positions around the amino nitrogen of cytosine 
In order to study the interactions between formaldehyde and DNA with WC or HG 
pairing, we considered DNA structures that include the ACA triplet, docked 
formaldehyde to the structures without any constraints on the binding site, and clustered 
the low energy poses using a 2.5 Å clustering radius (see Methods). As expected for small 
ligands (Krueger, Protozanova and Frank-Kamenetskii, 2006), low energy formaldehyde 
clusters were located in all hot spots shown in Figure 2.2, including the minor and major 
grooves. To find the most likely formaldehyde position in the major groove and in a 
region with preference for a carbonyl group, we applied a recently introduced filtering 
algorithm (Kozakov, et al., 2011), and selected the formaldehyde pose that overlaps with 
the highest population cluster of CO groups identified by the mapping as described in the 
previous section. Since we used a small (1.5 Å) radius, the CO cluster is small, and this 
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approach selects a single formaldehyde pose, discarding potentially spurious poses that 
arise from docking. Figure 2.6 shows the density of low energy formaldehyde poses  (in a 
transparent surface representation) and the selected formaldehyde pose for HG (purple) 
and WC (green) pairing, indicating that both the density of poses and the lowest energy 
formaldehyde position are shifted closer to the amino nitrogen by approximately 1 Å 
upon the WC to HG flipping. Figure 2.6B shows the distributions of formaldehyde 
positions in the hot spot around the amino nitrogen for DNA with HG and WC pairing. 
According to these results, for the ACA triplet the distribution shifts toward the amino 
nitrogen in the HG pair by more than 1 Å.	  Thus, the formation of an HG pair next to the 
C•G pair entails the formation of a formaldehyde cluster located in the major groove in 
close proximity to the cytosine amino group’s nitrogen.  As a result, a significant fraction 
of molecules in the cluster become very well positioned to attack the nitrogen lone pair 
with formaldehyde’s carbon atom, exactly the mechanism for the amino group 
hydroximethylation, according to ab initio quantum mechanical data (Hall and Smith, 
1998, Liao, Ding, Yu, Fang and Liu, 2007).  For the GCA triplet the shift of the 
formaldehyde cluster toward the amino nitrogen atom is somewhat smaller, but it is still 
substantial, confirming that the increased access of formaldehyde to the amino nitrogen 
atom remains valid, independently of the nature of the HG pair adjacent to the cytosine 
under consideration. 
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Figure 2.6 Formaldehyde positioning near the amino nitrogen atom of cytosine. (A) Superimposed formaldehyde 
(sticks) positioning near the amino nitrogen atom (blue sphere) of cytosine in DNA with Hoogsteen pairing (purple) 
versus Watson-Crick pairing (green) at the adjacent base pair. The density map shows distribution of low energy 
formaldehyde positions.  (B) Distributions of formaldehyde positions around the amino nitrogen atom for DNA with 
HG and WC pairing. 	  
To further prove that only amino nitrogens next to an HG pair are accessible for 
formaldehyde molecules, we have docked formaldehyde to four additional B-DNA 
crystal structures of good resolution, all in WC pairing (Table 2.2). Results show that 
formaldehyde molecules cluster predominantly in the minor groove of the DNA double 
helix, whereas the cytosine amino group is located in the major groove.  In all cases, 
either no cluster was observed in the major groove at all, or a cluster similar to one in 
Figure 2.6A was formed, always at least 4 Å apart from the cytosine amino nitrogen (data 
not shown). This makes it impossible for formaldehyde molecules within the cluster to 
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attack the nitrogen lone pair, which is a necessary condition for the amino group 
hydroximethylation (see, e.g. (Hall and Smith, 1998, Liao, Ding, Yu, Fang and Liu, 
2007)). This demonstrates that the reactive CO group interacts with the amino nitrogen of 
the adjacent cytosine only in DNA structures with HG pairing. This result extends to 
other aldehydes. We have performed CO density assisted docking of acetaldehyde to HG 
pairs, which revealed that the results are almost identical with the ones we have obtained 
for formaldehyde (Figure 2.7, data not shown). 
 
 
Table 2.2 Available crystal structures of B-DNAs with resolution better than or equal to 2.1 Å (resolution of 
1k61) 
PDB Code Sequence (5’-3’) Resolution (Å) 
307d caaagaaaag 1.85 
1bna cgcgaattcgcg 1.90 
126d catggccatg 2.00 
1hq7 ccaaacgtttgc 2.10 
	  
	  
	  
Figure 2.7 Acetaldehyde pose near the amino nitrogen atom of cytosine. Lowest energy acetaldehyde pose (stick 
model), overlapping the highest population cluster of CO groups (shown in mesh representation) for the GCA triplet 
with HG pairing. 
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2.4 Discussion 
The substantial increase in the availability of DNA structures in the Protein Data Bank 
(Berman, et al., 2000), coupled with improved modeling and visualization tools (Petrey 
and Honig, 2003, Jo, Vargyas, Vasko-Szedlar, Roux and Im, 2008, Zheng, Colasanti, Lu 
and Olson, 2010), demonstrated that interactions between DNA and other molecules, 
including proteins and small ligands, frequently occur in non-canonical regions of the 
DNA (Rohs, et al., 2009, Gao and Skolnick, 2009, Ma, et al., 2008, Ma, Chan, Lee, 
Kwan and Leung, 2011). In particular, we already mentioned that flipping of WC pairs 
into HG pairs was observed in a complex of DNA with the p53 protein (Kitayner, et al., 
2010). Thus, it is expected that the spontaneous transition to HG pairing, as demonstrated  
by Al-Hashimi and co-workers (Nikolova, et al., 2011), will influence the binding 
properties. Here we show, for the first time, that the HG pair formation indeed affects 
binding as well as the reactivity of DNA.  We have chosen formaldehyde as a chemical 
agent and the cytosine amino group as the target.  Our data show a dramatic effect of HG 
base pairs on the accessibility for formaldehyde attack of the amino group of cytosines 
adjacent to HG pairs.  Indeed, in the case of the all-WC duplex, either no cluster is 
formed in the major groove or the closest formaldehyde cluster is located in the major 
groove farther than 4Å from the amino group’s nitrogen. By contrast, when an HG base 
pair is next to the WC GC pair under consideration, the cluster forms near the cytosine 
amino group and a significant portion of formaldehyde molecules in the cluster have 
orientation favorable for attacking the nitrogen lone pair, which is the initial step of 
hydroxymethylation.  Thus, our hot spot mapping data indicate that while the all-WC 
	  	  
24 
duplex must be totally non-reactive for formaldehyde with respect to the cytosine amino 
groups, the formation of HG pairs makes these groups’ hydroxymethylation very much 
possible.   
How do our results, together with the HG breathing concept (Nikolova, et al., 2011), fit 
the extensive literature on DNA reaction with formaldehyde?  To answer this question let 
us first briefly summarize the picture of DNA reaction with formaldehyde as it emerged 
on the basis of extensive experimental and theoretical studies made over two decades ago  
(Lazurkin, Frank-Kamenetskii and Trifonov, 1970, Utiyama and Doty, 1971, McGhee 
and von Hippel, 1975, McGhee and von Hippel, 1975, Lukashin, Vologodskii, Frank-
Kamenetskii and Lyubchenko, 1976, Frank-Kamenetskii, 1983, Frank-Kamenetskii, 
1985, Frank-Kamenetskii, 1987). 
Formaldehyde hydroximethylates amino and imino groups of DNA bases.  However, the 
rate constants and the equilibrium constants of the reaction significantly differ for 
different groups (McGhee and von Hippel, 1975, McGhee and von Hippel, 1975): 
(i) The guanine imino group is not hydroximethylated  
(ii) The thymine imino group’s  reaction with formaldehyde is characterized by 
very high forward and reverse kinetic constants, which both strongly depend 
on pH, while their ratio, the equilibrium constant, is pH-independent and is 
much smaller than corresponding constants for amino groups 
(iii) The cytosine amino group has the largest forward kinetic constant and the 
largest equilibrium constant of reaction thus playing the leading role among 
amino groups.  
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Although reactions with guanine and adenine amino groups have to be 
allowed for in a quantitative theoretical analysis, they are much less important 
than the reaction with cytosine amino group and can be neglected within the 
first approximation 
In WC pairs, imino groups are totally inaccessible for reaction. Therefore, the imino 
reaction may proceed exclusively due to base pair breathing.  Traditionally, it has been 
assumed that only base pair openings make imino group’s hydroxymethylation possible.  
Discovery of the HG breathing does not change the situation.  Indeed, the thymine imino 
group remains inaccessible in the HG A•T pair (see Figure 2.1).  While in case of the HG 
G•C+ pair the guanine imino group does not participate in the inter-base hydrogen 
bonding, this is immaterial since guanine imino group does not react with formaldehyde 
anyway (see (i) above).  Thus, only full breathing, consisting of base pair openings, can 
allow imino group hydroxymethylation.  And, obviously, the corresponding A•T base 
pair must remain open as long as the imino group remains hydroxymethylated.  We 
conclude that with respect to reaction with imino groups the traditional picture based on 
only one breathing mode (base pair openings, see (Lukashin, Vologodskii, Frank-
Kamenetskii and Lyubchenko, 1976)) remains unchanged when accounting for HG 
breathing.  
Let us turn now to the amino group reaction. Due to item (iii) above, we will consider 
only the reaction with cytosine.  In contrast with imino groups, reaction with amino 
groups does not prevent the reformation of WC base pairs, although such pairs containing 
hydroxymethylated amino group are weakened (McGhee and von Hippel, 1977).  Now 
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we approach the central point of our analysis.  Does reaction with amino groups 
necessarily require “deep” breathing (base pair openings) or it is possible otherwise?  
Since, in contrast to imino groups, cytosine amino groups are not buried deep inside the 
double helix but are located at the bottom of the major groove, one can assume an 
“outside” reaction of formaldehyde with the cytosine amino group, which somehow 
proceeds in the all-WC B-DNA although much slower than in open pairs (Frank-
Kamenetskii, 1985, Frank-Kamenetskii, 1987, Demidov, 1980).  But the results presented 
here make this reaction route very unlikely: they do not leave any possibility for 
formaldehyde molecules to attack the cytosine amino group in all-WC B-DNA.  At the 
same time, detailed computer simulations of the kinetics of DNA reaction with 
formaldehyde showed that the overall reaction was significantly slower than in 
experiment if the reaction with amino groups could proceed only via full base pair 
openings (Frank-Kamenetskii, 1983, Frank-Kamenetskii, 1985).  That is why the 
“outside” reaction was invoked in the first place ((Frank-Kamenetskii, 1985, Frank-
Kamenetskii, 1987); note that the “outside” reaction was also detected by Demidov in 
specially designed DNA melting experiments (Demidov, 1980)).   
It was understood that the “outside reaction” could be a result of some base pair 
“breathings” other than full base pair openings (Frank-Kamenetskii, 1985, Frank-
Kamenetskii, 1987, Demidov, 1980) but the nature of these fluctuations has remained a 
total mystery over the past 25 years. The results presented here suggest that the “outside” 
reaction may proceed due to HG breathing, which makes amino groups of cytosines 
adjacent to transiently formed HG base pairs readily accessible for formaldehyde attack.  
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The slow-down of the “outside” reaction as compared to unsheltered cytosines (which is 
about 10-2 ((Frank-Kamenetskii, 1985, Frank-Kamenetskii, 1987, Demidov, 1980)) may 
be roughly considered as an estimate of the probability of HG breathing, which is in 
reasonable agreement with the HG breathing probability based on NMR data (Nikolova, 
et al., 2011). Of course, this is only a very rough estimate since it is done under several 
assumptions, first of all that the rate of reaction for cytosine participating in WC pairing 
is the same as for free cytosine. 
Based on our current findings and on extensive computer simulations of the kinetics of 
DNA unwinding by formaldehyde (Frank-Kamenetskii, 1983, Frank-Kamenetskii, 1985, 
Frank-Kamenetskii, 1987), we arrive at the following picture of the process of DNA 
interaction with formaldehyde, which quantitatively explains all its features. When 
duplex DNA is exposed to formaldehyde, no hydroxymethylation is possible for the 
“ground” state of DNA, which is the all-WC B-form.  The process of 
hydroxymethylation proceeds via two types of fluctuations:  transient base-pair openings 
and transient flipping of WC pairs into HG pairs. The former events lead to a very fast 
formation of a stationary fraction of open A•T base pairs with hydroxymethylated 
thymine imino groups (see item (ii) above and computer simulations in (Frank-
Kamenetskii, 1983)), while the latter events lead to accumulation of substantially 
weakened G•hmC pairs, where hmC are cytosines hydroxymethylated by their amino 
groups.  Adenines in open A•T pairs as well as cytosines and adenines in the adjacent 
base pairs become easily accessible to hydroxymethylation by their amino groups 
because they are not protected any more by stacking with adjacent base pairs. In parallel, 
	  	  
28 
accumulation of weak G•hmC pairs results in local melting of weakened regions in DNA 
making all bases in the region fully accessible for reaction with formaldehyde. 
Eventually, accumulation of hydroxymethylated amino groups, of both cytosine and 
adenine, throughout DNA results in full separation of the DNA strands. 
As shown by our results, computational mapping provides a highly sensitive tool for 
determining the effects of DNA conformational changes on the binding of small 
molecules. The method has been used in similar fashion for the comparison of protein 
binding sites in different environments (Kozakov, et al., 2011, Hall, et al., 2011). 
Mapping exhaustively explores the rotational/translational space of each probe molecule 
on a dense grid, and thus in principle provides detailed information on the energy 
landscape. Since the number of conformations generated is close to a million, we can 
retain and analyze only a number of the lowest energy clusters, which describe the low 
energy regions of the landscape for each probe. However, these are the regions that are 
most likely to bind the probes, and the distributions of low energy probe positions 
provide more exhaustive information on the energy landscape than methods generating a 
finite number of trajectories (e.g., Monte Carlo, molecular dynamics, or Brownian 
dynamics). 
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CHAPTER 3 Mapping RNA Ensembles 
3.1 Introduction 
It is well understood that the binding sites of protein include hot spots, i.e., smaller 
regions of the binding site that are major contributors to the binding free energy 
(Clackson and Wells, 1995, DeLano, 2002).  Interactions with these hot spots are crucial 
for high affinity ligand binding, and they involve the most important regions of the 
ligands (Hall, et al., 2011, Hall, Ngan, Zerbe, Kozakov and Vajda, 2012). Proteins 
without such hot spots are unable to strongly bind small molecules, and are considered 
non-promising candidates with respect to drug discovery (they are called “undruggable”) 
(Hajduk, Huth and Fesik, 2005, Kozakov, et al., 2011). The analysis of small molecular 
inhibitors capable of disrupting protein-protein interactions revealed that the hot spots 
binding small molecules in the interface show remarkable structural similarity, in spite of 
the frequently very large conformational changes upon ligand binding (Kozakov, et al., 
2011). We have recently shown that similar binding hot spots are also present in the DNA 
double helix, and interact with molecules that bind to DNA with high affinity (Bohnuud, 
et al., 2012).  
The goal of the present work is to extend the study the binding hot spots to RNA 
molecules. The interest to RNA a drug target has been exploding in the recent years 
(Cooper, Wan and Dreyfuss, 2009).  This is due to, on one hand, the growing 
understanding of pivotal biological roles many classes of RNAs, some of which being 
discovered only recently, play and, on the other hand, better understanding the structure 
and dynamics of RNA molecules.   In particular, a broader dynamic view of the 
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conformations populating the energy landscape is widely recognized as essential for 
successfully implementing structure-based approaches in lead compound discovery and 
optimization (Bothe, et al., 2011, Stelzer, et al., 2011). The added complexity of 
analyzing RNA properties is that RNA molecules do not adopt a single conformation but 
rather exist as an ensemble of rapidly converting alternative conformations with the 
probability of each conformation being affected by cellular cues such as ligand binding to 
affect functional outcomes (Bothe, et al., 2011, Frank, Stelzer, Al-Hashimi and 
Andricioaei, 2009).  In spite of its extreme flexibility, even short RNA molecules are 
capable of binding small ligands with high affinity, and the flexibility may actually 
provide added binding promiscuity in terms of many different ligands interacting with 
RNA (Stelzer, et al., 2011). 
One of the best characterized RNA-based regulatory systems is the transactivation 
response element (TAR) of HIV-1 RNA (Aboul-ela, Karn and Varani, 1996). 
Transcription of HIV-1 RNA in infected cells is strongly activated by the complex 
between the viral Tat protein and TAR RNA, a 59-nt RNA found at the 5’ end of all 
nascent viral transcripts. Tat and its cellular cofactor, the transcription elongation factor-b 
(P-TEFb), are recruited to the elongating RNA polymerase II (RNAP II) through 
interactions with TAR and are required for reactivation of the integrated proviral genome 
in latently infected cells (Davidson, et al., 2009).  The Tat-TAR complex is an attractive 
target for developing new antivirals because the interaction between Tat and TAR is 
unique to the virus. The TAR RNA therefore represents a potential target for HIV therapy 
as well as a model system to deepen understanding of RNA–small molecule interactions 
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and the development of drugs for RNA targets in general. These considerations have led 
to the synthesis and evaluation of numerous small-molecule and peptidic inhibitors of the 
Tat-TAR interaction (Gallego and Varani, 2001, Murchie, et al., 2004).  
Exploring the binding hot spots of TAR RNA is a challenging problem. As mentioned, 
the molecule is highly flexible, and adopts a large variety of conformations. The structure 
of TAR consists of two double-strand stems connected by a very flexible bulge of three 
bases, which interacts with the Tat protein and provides a specific binding pocket for 
most of the small molecular inhibitors, and an apical loop that binds the P-TEFb protein. 
Although the structures of Tat-TAR and P-TEFb-TAR complexes have so far been 
inaccessible, complexes of TAR with Tat-derived peptides indicate that the protein-RNA 
interface is large (Davidson, et al., 2009, Davidson, Patora-Komisarska, Robinson and 
Varani, 2011). Since in the TAR-peptide complexes the apical loop turns toward the 
bulge region burying the peptide in a deep grove, it was suggested that the high affinity 
peptide binding is responsible for the conformational change.  Thus, it is important to 
determine which regions of TAR are most important for binding, and whether such sites 
are induced by the partner molecule (small inhibitor or peptide) or already exist in the 
ensemble of unknown TAR structures. 
The FTMap method was recently expanded to the analysis of nucleic acids (Bohnuud, et 
al., 2012), and it is used here, for the first time, to explore the binding hot spots of TAR 
RNA where the structure is extremely flexible. Our data clearly demonstrate that despite 
significant conformational variability of TAR RNA structure, hotspots are conserved, 
which thus explains good binding affinity of ligands.  In accordance with experimental 
	  	  
32 
data of Al Hashimi and co-workers (Bothe, et al., 2011, Stelzer, et al., 2011, Frank, 
Stelzer, Al-Hashimi and Andricioaei, 2009), our data show that all binding spots are not 
the result of induced fit but rather hot spots pre-exist in the NMR ensemble of unbound 
TAR structures, including some highly curved conformations that have been observed in 
complexes with high affinity peptides. We therefore demonstrate the usefulness of the 
FTmapping for analyzing dynamical ensemble of small RNA structures. Our approach 
gives insight to high affinity ligand binding to small highly flexible RNA. Our data 
demonstrate that an ensemble of unbound state contains information about ligand 
binding, which is possible to obtain without any experimental information about ligand 
bound structures. 
 
3.2 Material and Methods 
3.2.1 Structures of ensembles used for analyses 
We used the only ligand-free structure of HIV TAR RNA, PDB code 1ANR, which is an 
ensemble of 20 structures solved by solution NMR. The ligand-bound structures of TAR 
are 2L8H, 1UTS and 1LVJ from PDB. NMR ensemble of 29 unbound structures of Tau 
exon 10, PDB code 1QC8 was used. NMR 1EI2 was used as ligand-bound structure of 
Tau exon 10. 
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3.2.2 Computational solvent mapping 
The FTMap algorithm (Brenke, et al., 2009) was extended for application to nucleic acids 
(Bohnuud, et al., 2012), and is available as a beta version at http://ftmap.bu.edu/beta. 
FTMap scans the entire surface of the nucleic acid with a library of 16 small organic 
probe molecules, with varying hydrophobicity and hydrogen bonding capability. For each 
probe, six probe clusters with the lowest mean interaction energies are retained. The 
clusters from the different probe types are then clustered into consensus sites (CSs), 
which define hot spots where multiple probes congregate with high affinity. The CSs are 
ranked on the basis of the number of probe clusters they incorporate, with the largest CSs 
representing the most important sites. More details of the method are provided in 
(Bohnuud, et al., 2012). 
 	  
3.2.3 Calculation of mapping fingerprints 
We calculate the hit rate of each of the RNA nucleotides, defined by number of non-
bonded interactions (atoms within a distance of 4 Å) made between atoms of it and all the 
probe clusters retained in FTMap. Similar to proteins where we have shown that residues 
with high hit rates have a higher probability to have favorable interactions with ligands, 
the hit rates here show the binding propensities of the RNA nucleotides. Even though all 
structures in an ensemble consist of same sequence and even secondary structures, the 
dynamics in the tertiary conformations make each structure exhibit a unique combination 
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of nucleotide hit rates. Here we define this signature probes contact profile for each 
structure in an ensemble a mapping fingerprint. 
 
3.2.4 Predict ligand binding nucleotides from averaged mapping fingerprints 
For each ensemble a general fingerprint is calculated by averaging over all the individual 
structures’ mapping fingerprints. This fingerprint is used to predict the ligand binding 
site. Since we consider small RNAs all nucleotides are proximal and comprise one major 
binding site.  Thus all nucleotides with hit rates higher than 4% of total non-bonded 
interactions are defined as binding site nucleotides and are used in following analyses. 
 
3.2.5 Correlation between one mapping fingerprint and ligand fingerprint. 
In a manner similar to mapping fingerprint, we define the ligand fingerprint as the profile 
of non-bonded interactions each of the RNA nucleotides make with the ligand, observed 
in the experimentally determined structures. Since all ligand-bound structures we use 
here happen to be NMR ensembles as well, we use the average fingerprint to represent a 
ligand-RNA interaction. We then simply calculate the Pearson correlation coefficient 
between these two vectors of fingerprints. Only the common nuclear nucleotides between 
bound and unbound structures were used in calculation. 
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3.2.6 Correlation between binding site hit rates and bound state resemblance 
Since a binding site can be defined as in last paragraph, its hit rate is simply the sum of 
hit rates of all nucleotides it contains. So far for each structure in an ensemble, the 
binding site hit rate and the resemblance (score) are defined. Within an ensemble, we 
calculate the Pearson correlation between these two vectors. 
 
Table 3.1 Average probe nucleotide hit rates of TAR. Binding site residues are in bold. 
Nucleotides	   Hit	  rate	  
G26	   0.07265	  
C39	   0.0709	  
G28	   0.0698	  
A27	   0.067	  
U40	   0.06575	  
G34	   0.0655	  
U23	   0.0417	  
G36	   0.0381	  
G33	   0.0371	  
C30	   0.03685	  
C29	   0.0354	  
U25	   0.03435	  
G21	   0.0315	  
C41	   0.0309	  
C24	   0.03085	  
A22	   0.03015	  
U31	   0.02855	  
U38	   0.02675	  
G32	   0.0259	  
A35	   0.02575	  
U42	   0.02515	  
C37	   0.02295	  
A20	   0.0201	  
G43	   0.01955	  
G18	   0.015	  
G17	   0.0093	  
C19	   0.0085	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C44	   0.0078	  
C45	   0.0066	  
 
Table 3.2 Average probe nucleotide hit rates of Tau exon 10. Binding site residues are in bold. 
Nucleotides	   Hit	  rate	  
U6	   0.0881	  
C18	   0.0580	  
U8	   0.0557	  
A13	   0.0553	  
C20	   0.0487	  
G5	   0.0480	  
A19	   0.0475	  
C22	   0.0473	  
U17	   0.0445	  
A21	   0.0443	  
U16	   0.0431	  
G7	   0.0425	  
A4	   0.0408	  
U12	   0.0384	  
G11	   0.0382	  
G9	   0.0359	  
C3	   0.0354	  
G1	   0.0343	  
C15	   0.0303	  
A10	   0.0278	  
C14	   0.0278	  
G23	   0.0252	  
G2	   0.0226	  
U24	   0.0144	  
C25	   0.0060	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3.3 Results and Discussion 
Our tool of determining the binding hot spots of RNAs is computational solvent mapping, 
implemented as the FTMap algorithm and server (Brenke, et al., 2009). FTMap samples 
probe-macromolecule interactions on a dense grid, finds favorable positions using 
empirical energy functions, clusters the conformations, and ranks the clusters on the basis 
of the average energy. For each probe, six bound probe clusters with the lowest mean 
interaction energies are retained. The clusters from the different probe types are then 
clustered into consensus clusters. The positions of the consensus clusters, termed 
consensus sites (CSs), define the binding hot spots where multiple probe molecules bind, 
identifying the regions most likely to bind small ligands.  The CSs are ranked on the basis 
of the number of probe clusters they incorporate. In case of proteins, largest CSs 
represent the most important hot spots, in good agreement with the results of screening 
libraries of small molecules using X-ray crystallography (Mattos and Ringe, 1996) or 
NMR (Liepinsh and Otting, 1997) for detection. It was shown that the mapping of 
proteins is able to identify residues where most optimal binding should happen. We have 
used FTMap to show the hot spots in interfaces in protein-protein complexes were 
conserved despite the flexibility of the interface.  
To identify important hot spots of TAR RNA by the FTMap method, we have considered 
the 20 structures within an NMR ensemble (PDB ID 1anr). For each structure we built a 
hit rate probe profile defined as the number of probe atoms interacting (within a 4A 
distance) with any atom of a nucleic acid base of TAR. Results are shown on Figure 3.1. 
We are using the hit rate profile to present mapping results rather than the location of 
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probe clusters, since the 20 structures of TAR RNA substantially vary due to the 
flexibility of the molecule. On the same plots we have marked bases (with blue asterisk) 
that interact with the two known high affinity (nanomolar) ligands of TAR RNA, P13 
(PDB id 1uts) and PMZ (PDB id 1lvj). According to these results, the majority of 
structures in the NMR ensemble have high hit rates at the bases that interact with the 
ligands. 
 
 
Figure 3.1TAR RNA nucleotide-probe hit rate profiles. Blue asterisks show nanomolar ligand (PDB ID 1uts P13) 
binding bases. 
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Figure 3.2a shows the summary hit rate for all 20 structures of the NMR ensemble and 
compares it to the hit rate profile of the nanomolar ligands. The hit rate profile from the 
mapping shows three major interaction peaks. C39 and U40 form the base of the bulge 
and consistently provide a binding hot spot in almost every structure of the ensemble.  In 
many structures C39 pairs with G26, which does become part of the same hot spot 
regions that bind major functional groups of the high affinity ligands.  The site in the 
middle is formed by G33 and G34 that are in the apical loop and generally have no 
hydrogen bonds, resulting in a pocket for binding small ligands. For example, the L8H 
(PDB ID 2l8h) binds at this region. The third peak at A27 and G28 occurs in structures in 
which the apical loop turns toward the bulge region, forming a large pocket. As 
mentioned, such TAR conformation occurs of complexes of TAR with high affinity 
peptides, but some weak small ligands (e.g., in the structure with PDB ID 1uud) also 
interact with this region. 
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Figure 3.2 TAR RNA cumulative hit rate profile compared with ligand profile. A) Ligand P13 and PMZ; B) ligand 
P13, PMZ and fragment L8H. Probes profile, blue, left axis; ligand, red, right axis. 	  
As we mentioned, a number of earlier publications describing TAR RNA structures with 
various ligands voiced the opinion that induced fit plays a major role in the different 
binding modes observed in the complexes.  Generating a dynamical ensemble of 
conformations, Al-Hashimi and co-workers have shown that this is not the case, as TAR 
RNA can be considered as an example of pre-existing conformations, and ligand binding 
simply contributes to the dominance of certain members of the ensemble, providing 
optimal interactions for the given ligand (Bothe, et al., 2011, Stelzer, et al., 2011, Frank, 
Stelzer, Al-Hashimi and Andricioaei, 2009). Our results show that all binding hot spots 
indeed pre-exist in the NMR ensemble of unbound TAR structures, including some 
	  	  
41 
highly curved conformations that have been observed in complexes with high affinity 
peptides.  
 
 
Figure 3.3 Tau exon 10 RNA cumulative hit rate profile. Probes hit rate, blue, left axis; ligand profile, red, right 
axis. 	  
To see whether this observation is specific to TAR RNA or a generic property of small 
RNAs, we have searched for other RNAs that have both unbound ensemble together with 
ligand bound structures. Due to such restrictions we have been able to identify only a 
single structure that satisfies those conditions, namely Tau exon 10. Figure 3.3 shows hit 
rate profile together with ligand contacts. Mapping identified key nucleotide bases 
responsible for known binding at bases A4, G5, U6, G7, U8, U16, U17, C18, together 
with additional hotspots at A13, C20 and C22.  Similar to TAR RNA it is likely that 
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additional hot spots within binding sites may be used by other ligands. 
Encouraged by these results we went on for more detailed analysis of individual 
conformers of the unliganded ensemble. For each state we calculated correlation of 
mapping and ligand fingerprint, as described in the methods. Since in case of Tar RNA 
we have a several ligands - we have calculated correlations of mapping fingerprints both 
to individual and average ligand fingerprints, for each conformer of the ensemble. The 
results are shown in Table 3.3. First observation is the overall best agreement between 
mapping and individual ligand is achieved at different conformers for different ligands. 
This is important since it supports idea of multiple preexisting states, where some of 
those states can be stabilized by particular ligands. For instance Model 10 better agrees 
with 39nm nanomolar ligand P13, while Model 12 with another 100nm ligand PMZ, as 
seen in Table 3.3. Mapping and ligand fingerprints for corresponding ligands and states 
are shown at Figure 3.4a and 3.4b. As can be seen individual states mapping have much 
better agreement with the ligands than the average mapping results. Interestingly 
correlation of mapping to ligand binding is better for higher affinity ligands, implying 
that higher affinity ligands can better use of preexisting state, and require less induce fit 
to bind. For example 39nm ligand has best correlation 0.61, 100nm - 0.53, whereas 
fragment sized molecule doesn’t have states with good correlations.  Additionally 
combination of nanomolar ligands achieve slightly better correlation 0.62, which implies 
that some further ligand optimization could be possible. 
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Table 3.3 TAR binding site hit rate and correlation to ligand fingerprints. Ranked by hit rate. 
model	   hit	  rate	   correlation	  
to	  avg	  of	  
1lvj,	  1uts,	  
2l8h	  
correlation	  
to	  1uts	  
correlation	  
to	  1lvj	  
correlation	  
to	  2l8h	  
correlation	  
to	  avg	  of	  
1lvj,	  1uts	  
17	   0.628	   0.317888	   0.37171	   0.353477	   -­‐0.1412	   0.441596	  
10	   0.625	   0.47758	   0.60854	   0.391928	   -­‐0.14888	   0.621413	  
12	   0.564	   0.472667	   0.470886	   0.535844	   -­‐0.13572	   0.607293	  
3	   0.501	   0.345495	   0.315796	   0.466721	   -­‐0.13194	   0.465648	  
15	   0.494	   0.314896	   0.358519	   0.155127	   0.029509	   0.324904	  
7	   0.493	   0.366348	   0.383976	   0.388343	   -­‐0.10232	   0.468783	  
14	   0.48	   0.293324	   0.212345	   0.103553	   0.183812	   0.198783	  
16	   0.472	   0.527374	   0.58042	   0.159748	   0.151503	   0.47631	  
1	   0.469	   -­‐0.08689	   0.023289	   -­‐0.02339	   -­‐0.14746	   0.002912	  
20	   0.467	   0.113794	   0.207408	   0.016823	   -­‐0.03585	   0.148315	  
average	   0.4533	   0.392923	   0.400279	   0.312798	   -­‐0.01321	   0.438649	  
2	   0.451	   0.51583	   0.398212	   0.303085	   0.199213	   0.431981	  
4	   0.447	   0.367453	   0.442908	   0.13267	   0.049203	   0.369319	  
8	   0.433	   0.121649	   0.059639	   0.14593	   0.020668	   0.119358	  
19	   0.412	   0.481296	   0.577247	   0.217385	   0.031669	   0.505517	  
13	   0.41	   0.30789	   0.371394	   0.465669	   -­‐0.24915	   0.502382	  
11	   0.374	   0.118534	   -­‐0.04396	   0.141869	   0.123489	   0.047634	  
6	   0.373	   0.219255	   0.241394	   0.065226	   0.063873	   0.197436	  
5	   0.359	   0.092778	   0.070751	   0.349846	   -­‐0.20496	   0.237681	  
18	   0.325	   0.067249	   -­‐0.17997	   -­‐0.11245	   0.384504	   -­‐0.1819	  
9	   0.289	   -­‐0.09632	   -­‐0.11618	   -­‐0.13146	   0.066298	   -­‐0.14943	  
 
Similarly for Tau Exon 10, Model 10 of the ensemble has excellent agreement with the 
ligand fingerprint as seen in Table 3.4 and Figure 3.4c. 
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Figure 3.4 Individual structure's mapping fingerprints compared with ligand's. A) TAR RNA model 10 and (B) 
model 12, C) Tau exon 10 model 10. Probes, blue, left; ligand, red, right. 
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Table 3.4 Tau exon 10 binding site hit rate and bound state correlation. 
model	   hit	  rate	   correlations	  
10	   0.79807	   0.829403	  
7	   0.784439	   0.813678	  
24	   0.759351	   0.748706	  
20	   0.748198	   0.423282	  
11	   0.740838	   0.727405	  
4	   0.736481	   0.736553	  
23	   0.720446	   0.628381	  
22	   0.715005	   0.244078	  
14	   0.705228	   0.696798	  
3	   0.703163	   0.402061	  
5	   0.691509	   0.527026	  
2	   0.683417	   0.591855	  
6	   0.669862	   0.731547	  
15	   0.669237	   0.421765	  
27	   0.666401	   0.226595	  
12	   0.666181	   0.427211	  
average	   0.663823	   0.748881	  
28	   0.663242	   0.165101	  
1	   0.663073	   0.41014	  
19	   0.662349	   0.276084	  
8	   0.651119	   0.461002	  
9	   0.646694	   0.253504	  
29	   0.622069	   0.64675	  
26	   0.617164	   0.403236	  
25	   0.591543	   -­‐0.05038	  
13	   0.583505	   0.251445	  
18	   0.567133	   0.184042	  
21	   0.561146	   0.161736	  
17	   0.483031	   -­‐0.20551	  
16	   0.480973	   -­‐0.09912	  
 
Our next question was whether there is anything special about configurations, which have 
high correlation between the mapping and ligand fingerprints. Our assumption is that the 
states which more likely to bind ligand should interact with more probes, at the binding 
site of interest. As seen in Figure 3.2b and 3.3 for TAR RNA and Tau Exon 10, 
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nucleotides with top hit rate describe the binding site pretty well. Thus we defined site hit 
rate as sum of hit rates of nucleotides which comprise the site. It should be noted that we 
don’t use any information about the ligand to define the site hit rate.  Site hit rate is 
shown in Table 3.3. Astoundingly conformers whose mapping results has the best 
correlation to bound ligands are within top best site hit rate conformers (namely top 2 and 
3), in good agreement with our assumption, that the higher the hit rate of the site in the  
particular state, the more relevant this state is to ligand binding. The same is observed for 
tau exon 10 as shown in Table 3.4 and Figure 3.4c, where the best correlation is achieved 
at the highest site hit rate conformer. Remarkably not only best agreement of ligand and 
mapping fingerprint happens to be among top 3 site hit rate states, but there is a good 
agreement between site hit rate and mapping/ligand fingerprint correlation, as seen in 
Figure 3.5 for TAR RNA (correlation 0.7) and Tau Exon 10 (correlation 0.82). This 
implies that dynamic ensemble of unliganded structure encodes information about 
potential interactions, and this information can be uncovered solely from the ensemble 
without using ligand information. 
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Figure 3.5 Binding site hit rate and bound state resemblance. A) TAR, B) Tau exon 10. Blue columns, probes hit 
rate; Red lines, correlation between mapping and ligand profiles. 
 
3.4 Conclusions 	  
In summary we demonstrated usefulness of mapping for dynamical ensemble of small 
RNA structures, gave insight to high affinity ligand  binding to small highly flexible 
RNA, and have shown that ensemble of unbound state contains information about ligand 
binding , which is possible to obtain without any information about ligand bound 
structures.  
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CHAPTER 4 PeptiMap 
4.1 Introduction 
Much of the maintenance of a cell is accomplished by communication between proteins. 
Such communication may involve complex layers of regulation that are mediated by local 
features, such as changes in local concentrations of the partners or / and post-translational 
modifications (Pawson and Nash, 2003, Akiva, Friedlander, Itzhaki and Margalit, 2012). 
These interactions are often weak and transient, and tuned so that the threshold of 
biological downstream response may easily be manipulated. Peptide – mediated 
interactions, in which a short, linear stretch binds to its protein receptor, are well suited 
for such transient binding, and therefore extensively used. In higher eukaryotes, up to 
50% of known interactions between proteins are indeed mediated by peptides (Petsalaki 
and Russell, 2008).  
The classical peptide-protein interaction involves (1) a short motif that is often embedded 
within an unstructured region, and (2) a peptide-binding domain with a defined globular 
structure. This interaction may occur between two distinct proteins, or within a protein, 
and the very competition between cis and trans interactions is often the very step that 
regulates protein function (Van Roey, Gibson and Davey, 2012).  
One of the important sources of information about interactions is the structure of a 
protein-protein complex. This structure can be used as a starting point for the 
characterization and manipulation of an interaction.  As an example, residues that are 
critical for an interaction may be identified using experimental or computational alanine 
scanning of interface residues(Morrison and Weiss, 2001, Kortemme, Kim and Baker, 
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2004, Zerbe, Hall, Vajda, Whitty and Kozakov, 2012, Zhu and Mitchell, 2011). 
Abolishment of an interaction by mutation of these critical residues may help identify the 
functional role of this interaction (Clackson and Wells, 1995). Finally, targeting of the 
interface of critical interactions by small molecules is gaining increasing importance in 
drug design, in addition to the traditional design of inhibitors of enzyme reactions (Wells 
and McClendon, 2007, London, Raveh and Schueler-Furman, 2013). 
While the number of experimentally solved structures is increasing, the fraction of 
protein complexes among these remains very low, around 10-20% (Berman, et al., 2002). 
This calls for the development of approaches that identify a binding site on a protein 
structure, or even better model the structure of a complex from the free monomers. 
Indeed, the field of docking, in which the structure of a complex is modeled from the 
structures of the free components, has significantly improved over the last 2 decades (see 
this CAPRI issue for some of the latest improvements).  
Identification of the binding site on a protein structure is a first step towards the 
generation of an accurate structural model of an interaction. If crucial residues that 
mediate the binding of two partners can be identified, this has two important effects: first 
of all, experiments can be directed towards those residues and the functional effect of an 
interaction may be studied. Secondly, docking approaches may be focused on a specific 
interface patch (London, Raveh and Schueler-Furman, 2013). For instance, we have 
previously developed a protocol that starting from a known binding site and an 
approximate peptide conformation within that site can accurately model the peptide-
protein complex structure (FlexPepDock (Raveh, London and Schueler-Furman, 2010, 
	  	  
50 
London, Raveh, Cohen, Fathi and Schueler-Furman, 2011)), even without any detailed 
knowledge of the peptide structure within the binding site (ab initio FlexPepDock 
(Raveh, London, Zimmerman and Schueler-Furman, 2011)). Thus, binding site 
identification allows to focus, and to intensify the search to relevant sites, rather than 
wasting time in a global full docking search, which can also result in additional false 
positives.  
Limited approaches have been proposed to identify peptide binding sites on proteins (e.g. 
references (Petsalaki, Stark, Garcia-Urdiales and Russell, 2009, Trabuco, Lise, Petsalaki 
and Russell, 2012, Verschueren, Vanhee, Rousseau, Schymkowitz and Serrano, 2013)). 
These use information both from the structures of the partners, as well as from the 
sequence. 
PepSite identifies peptide binding sites on protein structures by searching for regions that 
match a spatial PSSM derived from known peptide binding protein receptor structures 
(Petsalaki, Stark, Garcia-Urdiales and Russell, 2009). As such, it can not only identify the 
location of the peptide binding site, but also suggests a sequence motif for the binding 
peptides. Consequently, information about the actual peptide-binding partners is also 
provided. Another recently published approach uses the BRIX database of interacting 
fragments to predict the structure of peptide-protein complexes starting from a peptide 
sequence and a solved receptor structure (Verschueren, Vanhee, Rousseau, Schymkowitz 
and Serrano, 2013). 
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As for peptide binding sites, these existing methods perform well mainly on known 
binding sites, such as WW, SH3 and kinase domains, but less well on non-standard 
peptide-mediated interactions. Thus, new tools are needed to address this problem. 
Here we suggest an approach based on the observation that protein functional sites, 
including peptide binding sites, also bind small organic molecules of various shapes and 
polarity, as observed by nucleic magnetic resonance (NMR) (Hajduk, Huth and Fesik, 
2005) and X-ray crystallography experiments (Mattos and Ringe, 1996). FTmap (Brenke, 
et al., 2009) is a direct computational analogue of the above experimental approaches.  
This protocol is based on the successful FFT-based docking protocol with statistical 
potential (Kozakov, Brenke, Comeau and Vajda, 2006). We have recently reported 
application of this approach to ligand binding site identification (Ngan, et al., 2012) and 
druggable protein-protein interaction sites (Hall, et al., 2011), demonstrating broad range 
commonality of principles of molecular recognition. 
In this study, we have calibrated a protocol to detect peptide binding sites on protein 
structures. For this, we have adapted the mapping protocol to the identification of peptide 
binding sites. Two key differences distinguish peptide site prediction from ligand binding 
sites detection: (1) Prediction requires knowledge of the domain critical for peptide 
interaction: In contrast to proteins that bind ligands at one key site, multi-domain proteins 
can have multiple peptide regulatory sites on each of the domains and therefore focusing 
on one particular domain is recommended; (2) Peptides do not bind to inner buried sites 
of the proteins, which could well be ligand binding sites, and therefore these internal sites 
need to be removed. We show that with this tailored protocol, we can identify accurately 
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the binding site of a peptide within the top-3 sites in 19/21 (90%) of a benchmark set of 
curated peptide-protein complexes. We validate the approach on a set of peptide-protein 
structures that were released after calibration of the protocol: for 7/9 (78%) of the 
structures we reliably identify the peptide-binding site. In addition to the robustness of 
our protocol, our results also highlight features that characterize specifically peptide-
protein complex structures, and finally allow us to identify yet outstanding challenges in 
the modeling, and also the experimental identification of peptide-mediated interactions.  
 
4.2 Methods 
4.2.1 Compilation of training and test sets for protocol calibration 
In a previous study we have studied the special character of peptide-protein complex 
structures. For this aim, we collected PeptiDB, a set of 103 peptide-protein complexes 
that represent a set of different known peptide-mediated interactions (less than 70% 
sequence identity among different protein receptors), and a more restricted set of 61 
complexes in which no two proteins share the same fold (according to CATH 
classification) (See reference (London, Movshovitz-Attias and Schueler-Furman, 2010) 
and Table S1 therein).  
In the present study, our aim is to identify the peptide binding site on the protein surface. 
In order to prevent bias to bound sites on a protein structure, we needed to verify that the 
surface accessible to the peptide for binding on the receptor is indeed not occupied by 
any other protein or ligand. We therefore went over the original set and checked each 
protein-peptide interaction individually for the following features: 
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(1) Availability of the free receptor structure. We filtered for cases in which the 
corresponding free conformation has been solved by x-ray crystallography at 
reasonable resolution (<2.7Å), for a protein with full (>98%) sequence identity. 
(2) No bound ligands or proteins on the surface of the receptor. We verified that no 
ligands are bound to the protein surface, in particular not to the binding sites (e.g., 
for the PeptiDB entry 1T4D (mdm-x), we could not find a corresponding structure 
of the free mdm2 molecule without any ligand that had been solved by 
crystallography, and therefore we removed it from our set).  
(3) No crystal contacts that stabilize the binding site. Inspection of the symmetry 
mates in the solved crystal structures revealed that in certain cases the binding site 
of the free conformation binds to a peptide stretch of a copy of the protein in the 
crystal lattice (see for example PeptiDB entry 1DDW, the evh1 domain in the 
homer protein). In these cases, the peptide-binding site might have been arranged 
in a similar way as the bound conformation, and this might bias our protocol. 
(4) Biological unit of protein. In order to simulate accurately the accessible surface to 
the peptide, we included in the dataset the biological unit of the protein, e.g. a 
homodimer (see for example PeptiDB entry 2DS5 of the CLPX protease Zn 
binding domain).  	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Table 4.1 Benchmark and validation sets used for optimization and evaluation of PeptiMap peptide binding site identification. 
(A) Initial Calibration Benchmark (Extracted from PeptiDB 26; n=21) 
Name bound unbound Peptide sequence Cath domain domains/multimer treatment rank of hit Pepsite2
18 
ranks 
dystrophin 
(WW) 1EG4A 1EG3A_1 NMTPYRSPPPYVP
a 2.20.70.10 (
b; 
2x1.10.238.10) 
1 of 4 different 
domains (47-84) 
split: only 
first domain 
used 
2,3 6,8,10 
sh2a1 (SH2) 1D4TA 1D1ZA KSLTIYAQVQK 3.30.505.10    1  - 
lsb3 sla1 
(SH3) 1SSHA 1OOTA GPPPAMPARPT 2.30.30.40     2  1-6 
erbb2 (PDZ) 1MFGA 2H3LA EYLGLDVPV 2.30.42.10     1  - 
wdr5 
(WD40) 2H9MA 2H14A ARTKQT 2.120.10.80 
central hole not 
accessible to 
peptide 
mask 
internal 
sites 
3 1,3,5,6 
usp7 2FOJA 2F1WA GARAHSS NA* (β-sandwich)     1,2  1-6 
cyclophilin 1AWR 2ALFA HAGPIA 2.40.100.10   1 1-10 
p97 N-
glycanase 2HPLA 2HPJA DDLYG NA* (p97)     1  - 
traf2  1CZY 1CA4A ace-PQQATDD 2.60.210.10 weak homotrimer (ABC) 
use 
monomerc 3 -  
i-ap1 1JD5A 1JD4A AIAYFIPD 1.10.1170.10 weak homodimer  (AB) 
use 
monomer 1,2 4 
gga1 1JWG_AC 1JWFA DEDLLHI 1.25.40.90 
weak homodimer  
(AC - in bound 
structure) 
use 
monomer 2 -  
ntf2 1GYB_AB 1GY7_AB FSF  3.10.450.50 tight homodimer 
unit: 2 
chains 
1 
-  - 
Clpx 2DS8_AB 2DS5_AB ALRVVK NA* (clpx) tight homodimer, 2 sites 
unit: 2 
chains 1,2  - 
calpain 
small 
subunit 
1NX1A 1ALVAB DAIDALSSDFT 1.10.238.10 
tight homodimer 
central hole not 
accessible to 
unit: 2 
chainsc -  - 
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peptide 
ap2 2VJ0A 1B9KA_1 PKGWVTFE 2.60.40.1030  
2 domains 
split: both 
have 
peptide 
bound 
-  - 
    1B9KA_2 FEDNFVP  3.30.310.30 3  - 
pim1 kinase 
transferase 
domain 
2C3I 2J2IB_2 KRRRHPSG (3.30.200.20) 1.10.510.10 2 domains 
split: only 
second 
used 
2  - 
 cdk2 cyclin 2CCHB 1H1RB HTLKGRRLVFDN 1.10.472.10 x2 2 same domains  do not split 3 1,6 
trypsin 2AGEX 1UTNA Sin-AAPR 2.40.10.10 x2 2 same domains do not split 1 6 
Pcna 1RXZ 1RWZA KSTQATLERWF 3.70.10.10 2 same domains do not split 2  - 
Endothia-
pepsin 1ER8 4APEA PFHLLVY 2.40.70.10 2 same domains do not split 1,2,3 1-6 
(B) Validation set (Compiled from recent PDB releases 1-4/2013; n=9) 
Name bound unbound Peptide sequence Cath domain domains/multimer treatment rank of hit Pepsite2 ranks 
γ2 adaptin 
Ear domain 2YMT 4BCXA EWGPWV 2.60.40.1230 1 domain  3 - 
β cop WD40 4J73 3MKQA EAKKLV 
2x 2.130.10.10 + 
additional 
domain (based 
on 1VYH) 
3 domains 
central hole not 
accessible to 
peptides  
split, only 
first 
domain  
(2-300); 
site 1 
masked 
2,3 2,3,5,6 
RADa 4B3B 4A74A aceFHTA 3.40.50.300 (based on 1PZN) weak homodimer 
use 
monomer 2,3 - 
FKBP35 4ITZA 3NI6A sinALPFnit 
3.10.50.40 
(based on 
1KT0A) 
weak homodimer use monomer 1  1-10 
jnk1 kinase 
transferase 
domain 
3VUH 3ELJ PKRPTTLNLF (3.30.200.20); 1.10.510.10 2 domains 
split: only 
second 
domain 
-  1-10 
HIF alpha 4B7E 2W0X EVVKLLLEHGADVLAQD 2-305; 1.10.287.1010 2 domains 
split: only 
first 1,3 1,4,7-10 
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a Peptide residues accurately mapped by fragments are highlighted in bold and underlined; Peptide residues with 
area covered by fragments are highlighted in bold but not underlined  
b XX: unassigned domains 
c Better prediction obtained with SCOP classification (1CA4: 1,2 instead of 3), or domain parser (1ALV) 
* No domain assignment available based on CATH 
 	  
domain  
MLH1 mut 
alpha c-term  4FMNA 4E4WA VRSKYFK NA* multidomain 
too big 
without 
splittingc 
- 
No split 
informa-
tion 
available 
-  
demethylase 4FWF 4FWE ARTMQTARKSTGG 
(domain A02: 
280-405 & 522-
836, based on 
2V1DA)  
multidomain 
split: only 
second 
domain 
1  - 
ck2 kinase 4IB5 3BQC GCRLYGFKIHGCG 3.30.200.20; (1.10.510.10) 2 domains 
split: only 
first 
domain 
3 - 
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The resulting set for assessment is detailed in Table 4.1A. To assess the robustness of this 
protocol, we compiled an additional set by extracting peptide-protein complex structures 
that were released to the Protein Data Bank (PDB (Berman, et al., 2002)) after the 
development of PeptiMap (between the dates 1.1.2013-8.4.2013) and filtered according 
to the same guidelines as detailed above. Only protein receptor structures not structurally 
similar to the entries in the training set were retained (i.e. distinct CATH domain 
(Greene, et al., 2007)). This validation set is detailed in Table 4.1B.  
 
4.2.2 Definition of the functional unit that will be mapped 
Similar to its experimental counterpart, Structure-Activity-Relationship (SAR)-NMR 
(Shuker, Hajduk, Meadows and Fesik, 1996), our computational solvent mapping 
approach is aimed at targeting distinct “physiological units”, namely globular domains 
that form a stable unit and together act as a receptor. As an example, a tight dimer 
receptor will be defined as one physiological unit to map. On the other hand, when a 
protein is composed of distinct domains that can move one relative to the other, we 
expect each to act as an individual binding site to a peptide, and therefore each should be 
treated as a distinct physiological unit.  Based on this rationale, we have devised the 
following rules by which we define the individual units that are separately mapped: 
a).  For "tight" multimers (ratio of buried surface area of the monomer >0.2, see for 
example 1GY7), the individual unit is defined as the full multimer. 
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b) If a protein consists of more than one domain, all of the same class (i.e. repeated 
domains), we do not split the protein into individual domains, but rather treat it as 
one individual unit. 
c) If the protein consists of different domains, split these into individual domains 
and perform solvent mapping separately on the domain that is known to be critical 
for the interaction (if such information is not available, each domain should be 
screened separately). 
 
4.2.3 Separation of receptor structure into distinct domains 
In order to map the fragments onto individual domains, the protein receptor structure was 
decomposed into these domains based on CATH domain classification (v3.4). In cases 
where no CATH classification was available, we identified the most similar CATH 
domain using sequence alignments. 
 
4.2.4 Detailed outline of protocol 
The protocol consists of a series of steps described below. First, the “physiological unit” 
of the protein receptor is defined (as detailed above). The next steps (2-7) are identical to 
the FTsite protocol used to identify protein and ligand binding sites (Ngan, et al., 2012). 
The final steps (8-10) include the removal of sites involved in domain interactions, the 
merging of adjacent clusters, and finally the filter of internal sites not accessible to the 
peptide. Here we summarize the protocol shortly, and where appropriate highlight the 
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changes specific to peptide binding site identification that were incorporated into 
PeptiMap. Steps new to PeptiMap are highlighted in bold. 
Step 1: Selection of “physiological unit”. Decomposition is based on annotation of 
protein domains according to CATH (the rules for decomposition are outlined above and 
more detailed in the Results section).  
Step 2: Grid-based sampling of the protein surface with FFT. All bound ligand water 
molecules and other ligands are removed prior to the calculations. We then sample the 
protein surface for 16 small molecule probe types (Brenke, et al., 2009). This is done 
using exhaustive sampling with grid-based Fast Fourier Transform (FFT) (109 docked 
probe positions). The best 2,000 poses with the lowest energies for each probe type are 
retained. 
Step 3: Post-FFT clustering to discard spurious probe clusters. For each probe type, the 
2000 retained poses are clustered using a simple greedy algorithm. We select the lowest 
energy pose as the center of the first cluster, and add all poses within 4Å center-to-center 
distance from it as cluster members (Kozakov, Clodfelter, Vajda and Camacho, 2005). 
All clustered poses are removed, and we repeat the same steps to form the second and 
then the subsequent clusters until all poses are clustered. Clusters with less than 10 
probes are removed, and the 6 largest clusters are retained for further analysis.  
Step 4: Minimization and re-scoring. The energy of each retained protein-probe complex 
is minimized using the CHARMM (Brooks, et al., 2009) potential with the Analytic 
Continuum Electrostatic (ACE) model representing the electrostatics and solvation terms 
as implemented in version 27 of CHARMM. The algorithm uses the polar-hydrogen-only 
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parameter set from version 19 of CHARMM. The energy minimization is performed 
using a limited memory Broyden–Fletcher–Goldfarb–Shannon (L-BFGS) method in 
which heavy atoms of the protein are held fixed, while the polar hydrogen atoms of the 
protein and all atoms of the probes are free to move. Poses with positive energies after 
minimization are discarded. 
Step 5:  Generating consensus clusters. Following the energy minimization we re-cluster 
the resulting probe poses. As in Step 2, we select the lowest energy pose as the center of 
the first cluster, but use 4 Å full-atom pairwise RMSD as the clustering radius. After all 
probes are clustered and clusters with less than 10 members are discarded, the clusters are 
ranked on the basis of the Boltzmann averaged energy, and the 6 lowest energy clusters 
are retained for every probe type. Consensus clusters are generated by grouping probe 
clusters with cluster centers within 4 Å. The centers of the resulting consensus clusters 
are fixed, and the probe clusters are re-distributed such that each cluster center is closer to 
the center of its own consensus cluster than to the center of any other consensus cluster. 
Consensus clusters that overlap with an integral element of the intact protein such as 
heme are discarded. A consensus cluster is considered to overlap with a co-factor if their 
volume overlap exceeds 80% of the consensus cluster. 
Step 6: Ranking consensus clusters.  The algorithm ranks the consensus clusters by the 
number of non-bonded contacts between the protein and all probes of the consensus 
cluster. A residue of the protein and a probe are considered to be in contact if any atom of 
the residue is less than 4 Å from any atom of the probe. A residue is considered to be in 
contact with a consensus cluster if it is in contact with any of its probes. After selecting 
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the contact residues for a consensus cluster we re-evaluate the number of contacts by 
adding also interactions with probes that are within 4 Å but are not part of the original 
consensus cluster. The resulting numbers are normalized using the overall number of 
contacts for all probes, and used for ranking the consensus clusters. 
Step 7: Identification of putative peptide binding sites. To identify the putative binding 
site, the algorithm first selects the consensus cluster with the highest number of contacts. 
This cluster is then expanded by adding any neighboring consensus cluster if the center of 
any of its probe is closer than 3.5 Å to the center of any probe in the consensus cluster. 
The protein residues that are within 4 Å of the expanded consensus cluster constitute the 
top prediction of the binding site. The first consensus cluster is then removed, and the 
procedure is repeated using the next consensus cluster with the highest number of 
contacts to identify lower ranked predictions of the peptide-binding site. 
Step 8: Discard sites located in non-accessible regions in the protein. Sites at the domain 
interface (in cases of proteins that were split into individual domains): If a putative site 
clashes significantly with secondary structures (α-helices or β-sheets) on the partner 
domain(s), the site is discarded. A putative site is discarded if the site is within 3.0 Å of 
one or more secondary structure-associated (helices or sheets) amino acids on partner 
domain(s) as defined by PyMol. This removes sites that are involved in domain-domain 
interactions.  
Step 9: Expand final sites that are retained. Each of the sites is expanded by adding to the 
site probe cluster representatives that are not already part of the site but are closer than 
4.0 Å (atom-atom distance) to probe cluster representatives that are already part of the 
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site. Probe cluster representatives that are already members of other sites are not used 
and, therefore, the sites are only expanded and not co-joined. 
Step 10: Remove inaccessible sites within the protein core: While the small molecules 
that are used to probe the protein surface may access internal cavities due to their small 
size, peptides are larger and therefore cannot reach these voids. At the same time such 
sites are attractive to probes since they provide much larger contact areas to a small 
molecule than the surface (and indeed they are good ligand binding sites). To adequately 
analyze peptide binding surface, such sites should therefore be excluded from mapping. 
In order to identify internal ligand binding sites, we building 100 rays uniformly covering 
a sphere (Yershova, Jain, Lavalle and Mitchell, 2010) from the center of the site, and 
identify which of those contact the protein (a contact is defined if a ray passes within 2 Å 
from the center of any atom of the receptor). A binding pocket is considered internal if 
80% of the rays contact the protein. Internal sites are masked and steps (2-10) are 
repeated. 
 
4.2.5 Assessment of performances: criteria for binding site identification 
Since peptide binding site identification criteria have not yet been established, we have 
employed accepted criteria used for ligand binding site identification (Huang and 
Schroeder, 2006). This criterion requires the geometric center of the predicted ligand-
binding site to lie within 4.0 Å of any peptide atom. This allows easy comparison to other 
approaches. Residues mapped by PeptiMap are shown in bold in Table 4.1, and residues 
	  	  
63 
for which side chain atoms have been accurately mapped at the same spatial position (i.e. 
within 2 Å).  
 
4.3 Results 
4.3.1 Compilation of curated benchmark set of peptide–protein complexes for peptide 
binding site prediction 
In order to allow the objective assessment of peptide binding site prediction, we compiled 
a set of protein structures of a free receptor that do not contain any other molecule at the 
peptide binding site (i.e. no other bound ligands, and no crystal contacts, see Methods for 
more detail). We then parsed the structures into domains and identified their biological 
units. Based on these, we defined the receptor structure and the surface to map for 
peptide binding sites. The same procedure was repeated on a second set compiled after 
this calibration (see Methods). The total of 30 peptide-protein complexes are detailed in 
Table 4.1A (benchmark of 21 interactions) & Table 4.1B (additional validation set of 9 
interactions). 
We would like to note that while the optimization set, and more so the test set, are rather 
small, they are non-redundant and therefore do represent a wide variety of different 
peptide binding domains. More importantly, considerable efforts were made to verify that 
these sets are clean and not biased to any bound conformation. In a real-world scenario 
the available template structure might well bind a symmetry mate or a ligand in the 
binding site – thus PeptiMap is expected to perform even better.  
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4.3.2 Adaptation of FTSite to prediction of peptide binding sites 
Computational fragment mapping can accurately identify small ligand binding sites 
(Ngan, et al., 2012), as well as locate druggable protein-protein interfaces (Kozakov, et 
al., 2011). Peptides lie in between these two cases: In contrast to ligand binding sites, 
peptide binding sites tend to be more shallow and the pockets to be smaller. In contrast to 
protein binding sites, peptides tend to bind to smaller regions and with usually weaker 
affinity. We wanted to optimize PeptiMap to specifically identify peptide-binding sites 
(noting that such modifications might improve predictions of binding sites of larger 
ligands as well). Two major modifications were necessary to provide a robust protocol 
for peptide binding site location on protein structures, namely (1) the decomposition of 
protein structures into physiological, functional units, and (2) filtering out internal ligand 
binding sites not accessible to peptides.  
(1) Decomposition of protein structures into physiological, functional units 
Assuming that a peptide will bind to an organized binding site, we decompose the protein 
structure into independent parts that represent the stable functional unit a peptide might 
encounter. Splitting a protein structure into individual domains prevents the identification 
of short-lived crevices at the boundary of the domain interface as peptide binding sites, 
and reduces the surface to be sampled (see Table 4.1, and Figures 4.1 A&B for the 
example of ck2 kinase, pdb ID 3BQC).  
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Figure 4.1 Examples of predictions of peptide binding sites using PeptiMap. The same color-coding scheme is used 
in all figures: The receptor is shown as a cartoon colored in cyan, while the different predicted sites are shown in 
surface representation (top-ranking site – wheat; site 2 – green; site 3 - dark blue). The peptide is shown in stick 
representation and colored according to the predicted binding sites (residues that do not contact any predicted site are in 
light grey). Pdb IDs of the apo and bound structures are indicated in parentheses. Predictions were made on the apo 
structures; bound structures are for validation purposes only.  
(A,B) Mapping on single domains improves peptide binding site prediction on ck2 kinase (apo: pdb ID 3BQC chain 
A): (A) mapping on the full structure identifies merely a known ligand binding site (pdb ID 3U4U), while (B) mapping 
on the n-terminal kinase domain only identifies the peptide binding site (pdb ID 4IB5; the transferase domain not 
mapped here is shown in dark blue). This highlights how implementation of segmentation into single domains may 
improve in particular peptide-binding site predictions (while small ligands can be identified also on the full structure).  
(C) Example of accurate PeptiMap prediction of the peptide binding site covering a substantial part of the peptide: 
Endothiapepsin peptide binding site prediction identifies the peptide binding site of all but one residue (apo: pdb ID 
4APE chain A; bound: 1ER8). (D,E) Masking of internal ligand binding sites improves peptide binding site prediction 
on coatomer b subunit. (D) In the original prediction, mapping of the receptor structure (pdb ID 3MKQ chain A) 
identifies mainly peptide-inaccessible sites within the whole of the WD40 domain, but not the peptide binding site (pdb 
ID 4J73). (E) When entrance into the inner cavity is blocked, PeptiMap identifies correctly the location of the peptide-
binding site. (F) Example of target failed by Peptimap.  In case of the AP-2 complex subunit alpha (CATH domain 
2.60.40.1030; pdb ID 1B9K), the peptide binding site (from pdb ID 2VJ0) is not identified by the top 3 predictions, 
only by prediction ranked 4th (in yellow). 
In contrast, tight homo-multimers (e.g. Clpx, pdb ID 2DS5), as well as repeated same 
domains within a protein (that in general also form tight interactions) are merged into one 
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functional unit for mapping (e.g. Figure 4.1 C that shows Endothiapepsin chain A that is 
composed of two identical domains according to the CATH classification).  
(2) Filter out internal binding sites 
Fragment mapping will identify among others also ligand-binding sites within proteins 
that are not accessible to the larger peptide ligands. Removal of such sites using ray 
tracing (see Methods section) improved predictions of peptide binding sites of WD40 
domains that contain a hole at the center of the protein not accessible to peptides (Figures 
4.1D & 4.1E show how ranking is significantly improved by masking inaccessible 
internal ligand binding sites in the protein cop b, pdb ID 3MKQ chain A), and similar 
results were also observed on additional cases of known internal ligand binding sites 
(results not shown). 
 
4.3.3 PeptiMap accurately locates the peptide-binding site on most of the receptor 
structures in both the benchmark and validation sets, and compares very favorably to 
other approaches 
Using this streamlined protocol, PeptiMap identified 10 out of 21 (50%) peptide binding 
sites in the benchmark as the top-ranking prediction. More importantly, it failed only in 
two cases to identify the site among the top-3 ranking predictions (19/21 success rate; 
90%). In the independent subsequent validation, a lower performance was observed for 
top-ranking sites: 3/9 (33%) binding sites were top-ranked. However, again only two 
cases were not identified among the top-3 ranked predictions (7/9 successes; 78%). 
Details of performance for each of the proteins are given in Table 4.1. These results 
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demonstrate the general applicability of the protocol to a range of different peptide-
protein complexes, involving many different folds as well as many different functional 
classes.  
The predicted binding sites are in many cases very accurately mapped. Figure 4.1 C 
shows a particularly successful prediction: for Endothiapepsin, the accurate location of 
six out of seven peptide residues is identified by PeptiMap. Overall, 1 to 6 peptide 
residue positions (median of 2) are identified by PeptiMap (these residues are highlighted 
for each peptide in Table 4.1). It should be noted that this covers a significant part of the 
peptide residues that directly contact the receptor.  
We compared our protocol with other available approaches. PepSite is the only approach 
that can be tested and validated via a server. The coverage of this approach is rather 
restricted (due to limited availability of enough structures to create the structural PSSMs). 
We ran PepSite (version2 (Trabuco, Lise, Petsalaki and Russell, 2012)) on the same 
dataset in order to compare the two approaches. PepSite identified only 6 out of 21 
peptide binding sites in the benchmark set within the top1 predicted sites (same results 
for top3 assessment). The corresponding performance for the validation set of 9 cases 
was 3 top-ranking predictions and 4 predictions ranked 1-3.  
The recently published approach based on the BRIX database of interacting fragments 
(Verschueren, Vanhee, Rousseau, Schymkowitz and Serrano, 2013) reports results for a 
set of protein-peptide complexes. Among these we could find predictions for two of the 
proteins assessed here: for p97 N-glycanase (2HPJ) this approach failed to identify the 
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binding site, while an acceptable prediction was reported for PCNA (1RWZ), albeit not 
top-ranked.  
 
4.4 Discussion and Conclusions 
PeptiMap is a new, accurate and robust approach for peptide binding site detection on 
protein receptor surfaces. It is based on the successful computational fragment mapping 
approach previously applied to ligand site prediction (Ngan, et al., 2012) and the 
detection of druggable protein interactions (Kozakov, et al., 2011). Overall the results 
presented here are promising and indicate that automated and efficient prediction of 
peptide binding sites on proteins is coming of age. Not only is the peptide binding site on 
the receptor surface identified for most of the cases among the top-3 ranking structures 
(26/30), but also the predictions are accurate and identify many of the important peptide 
binding residues. Furthermore, our results here suggest that PeptiMap clearly outperforms 
other available approaches, thanks to its general applicability and accurate prediction.  
In the following we shortly assess the challenges that need to be addressed to further 
extend performance of PeptiMap and suggest several ways to do so, based on the 
constraints of this approach and the cases where it still fails (see e.g. Figure 4.1 F for a 
peptide-binding site identified only by the prediction ranked 4th). 	    
	  	  
69 
4.4.1 Possible strategies to improve PeptiMap 
(1) Focused mapping: We have shown in several examples that once a site has been 
identified, focused local mapping can improve the coverage of the site, and provide 
general guidelines regarding peptide sequence preference (Zerbe, Hall, Vajda, Whitty and 
Kozakov, 2012, Golden, et al., 2013).  
(2) Improved definition of functional units: Preliminary results indicate that performance 
can significantly be affected by how the functional units are defined, in particular how 
the individual domain boundaries are determined. While CATH-based domain definition 
provides overall adequate functional units, in some cases we noticed that different 
definitions can dramatically improve performance (see Table 4.1). In particular for large 
proteins, when CATH provides no domain definition or does not split the protein into 
distinct domains, PeptiMap may fail to identify the peptide-binding site (e.g. pdb ID 
4E4W chain A and 1ALV chain B, see Table 4.1). In such cases, domain mapping based 
on alternative tools such as domainparser (Xu, Xu and Gabow, 2000), or on visual 
inspection could define a subdomain that is useful for peptide binding site detection 
(results not shown). 
 
4.4.2 Combination of PeptiMap with other approaches to characterize structure and 
specificity of peptide–protein interactions 
Currently, PeptiMap predicts the location of peptide binding sites, but does not provide 
any information about actual structure of the peptide within this site, nor about possible 
sequences for a binding peptide. In order to proceed to a full model of the peptide-
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receptor complex, PeptiMap predictions could serve as input for peptide-protein docking 
protocols (London, Raveh and Schueler-Furman, 2013, Trellet, Melquiond and Bonvin, 
2013). We plan to incorporate PeptiMap into a scheme for FlexPepDock (Raveh, London 
and Schueler-Furman, 2010, Raveh, London, Zimmerman and Schueler-Furman, 2011) 
that will allow for full ab initio prediction of peptide-protein complex structures starting 
from a given peptide sequence and a free receptor structure. 
In addition, while PeptiSite and the BRIX-based approach are less general, they do 
provide more information in their prediction, such as sequence-specific binding site 
identification, as well as an approximate structure of the peptide – protein complex. 
Therefore, combining information from different protocols that use rather complimentary 
approaches will ultimately improve our knowledge and understanding of peptide-
mediated interaction and their structural basis.  
 
4.4.3 Implications for globular protein–protein docking 
In a previous study we have suggested that a significant fraction of globular protein-
protein interactions is mediated by one linear, peptidic stretch that contributes most of the 
binding energy (e.g. a dominant loop at the interface) (London, Raveh, Movshovitz-
Attias and Schueler-Furman, 2010). Moreover, this study indicated that when bound to 
the protein partner, this peptide tends to adopt a structure that is very similar to the one 
adapted within the protein context. Consequently, PeptiMap could be used in a more 
general way to identify on a protein surface where such dominant peptidic stretches 
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would bind. While FTmap was shown to identify druggable sites on protein interfaces 
(Kozakov, et al., 2011), PeptiMap is expected to be very useful for the design of specific 
peptide-derived inhibitors of protein interactions. 
This study demonstrates the strength of non-biased, ab initio prediction protocols for 
finding molecular recognition sites of peptides. The general applicability of such an 
approach will substantially contribute to improved characterization of a range of peptide-
mediated interaction, and provides thus a good starting point for structure-based 
characterization of biological interaction and function. A server is under development to 
make PeptiMap generally available (and the PeptiMap software is freely available to 
academic users upon request). 	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CHAPTER 5 Protein Ensembles 
5.1 Introduction 
Reversible protein-protein interactions (PPIs) are involved at multiple points in virtually 
all biological pathways, including disease pathways where therapeutic intervention could 
bring widespread benefit, and hence are biologically compelling targets for drug 
discovery (Wells and McClendon, 2007, Whitty and Kumaravel, 2006).  A number of 
systems are known for which small molecules inhibit the interaction between two 
proteins, and substantial efforts have been devoted to developing methods to identify the 
PPIs that are druggable, i.e., will be able to bind a small molecule with high enough 
affinity to achieve inhibition (Kozakov, et al., 2011, Fuller, Burgoyne and Jackson, 2009, 
Blundell and Bolanos-Garcia, 2009, Zinzalla and Thurston, 2009). It is now well 
established that such sites must include binding hot spots, i.e., regions that are major 
contributors to the binding free energy, and must contain, or must be able to form, a 
pocket appropriate for accommodating a ligand of druglike dimensions (Kozakov, et al., 
2011).  
The traditional experimental method of finding hot spots is alanine scanning mutagenesis, 
which involves serially mutating each interface residue to alanine and measuring the 
impact of each mutation on the affinity for binding to the partner protein (Bogan and 
Thorn, 1998). On the basis of this method, a residue is considered a hot spot if its 
mutation to alanine gives rise to a substantial drop in binding affinity. An alternative 
experimental method, directly related to finding druggable sites, is based on screening 
libraries of fragment-sized organic molecules for binding to the target protein.  Since the 
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binding of the small compounds is very weak, the interactions are most frequently 
detected by X-ray crystallography (Mattos and Ringe, 1996, Ciulli, Williams, Smith, 
Blundell and Abell, 2006, Winter, et al., 2012) or nuclear magnetic resonance (Hajduk, 
Huth and Fesik, 2005). These approaches are now routinely used for fragment-based drug 
design (Hajduk and Greer, 2007).  It was shown that the small “probe” ligands cluster at 
hot spots, and that the hit rate predicts the importance of the site and its druggability 
(Hajduk, Huth and Fesik, 2005). For disrupting a protein-protein complex it is necessary 
to find a strong hot spot in the interface region of at least one of the component proteins 
(Kozakov, et al., 2011). Computational methods have also been developed for predicting 
the results of both alanine scanning (Kortemme and Baker, 2002, Huo, Massova and 
Kollman, 2002, Darnell, Page and Mitchell, 2007, Lise, Buchan, Pontil and Jones, 2011, 
Higa and Tozzi, 2009, Grosdidier and Fernandez-Recio, 2008, Tuncbag, Gursoy and 
Keskin, 2009) and fragment screening (Brenke, et al., 2009, Lexa and Carlson, 2013, 
Bakan, Nevins, Lakdawala and Bahar, 2012) experiments.  
Both computations and experiments show that the shape and the size of hot spots may be 
affected by conformational changes upon ligand binding (Kozakov, et al., 2011, Thanos, 
DeLano and Wells, 2006, Kuttner and Engel, 2012), but their locations are sufficiently 
robust to be detectable from the structures of ligand-free proteins, even when substantial 
conformational adaptation is required for optimal binding (Kozakov, et al., 2011).  In 
contrast, the existence of a pocket that is large enough to accommodate a drug-size ligand 
heavily depends on the conformation of the protein. In fact, the interfaces in X-ray 
structures of protein-protein complexes are frequently flat or have only small crevices, 
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and thus forming larger pockets must precede or accompany inhibitor binding. While 
induced fit may play a role, molecular dynamics, Monte Carlo, and other simulation tools 
show that a number of transitional pockets open up spontaneously, some of them having 
the right size for ligand binding (Eyrisch and Helms, 2007, Metz, et al., 2012, Kokh, et 
al., 2013, Johnson and Karanicolas, 2013), suggesting that the conformational selection 
model of the recognition process applies (Ma, Kumar, Tsai and Nussinov, 1999, Tsai, Ma 
and Nussinov, 1999, Boehr, Nussinov and Wright, 2009). Such pockets may appear at 
many different locations (Eyrisch and Helms, 2007), but it was recently shown that the 
druggable sites in protein-protein interfaces are more predisposed to surface pocket 
formation than the rest of the protein surface (Johnson and Karanicolas, 2013). In 
principle, simulations by molecular dynamics or Monte Carlo methods enable detailed 
understanding of the recognition process. However, the conformational transitions that 
are required for opening pockets are relatively rare on the time scales of ordinary 
simulations, and hence it may be necessary to introduce biasing assumptions that 
potentially affect the results (Johnson and Karanicolas, 2013).  
The goal of the present paper is to investigate the spontaneous formation of the potential 
ligand-binding pockets in protein interfaces by analyzing ensembles of ligand-free 
protein structures determined by NMR. Structures in NMR ensembles generally show 
substantial variation, both in terms of the overall root mean square deviation (RMSD) and 
in the region of ligand binding. Our analysis will answer a number of important 
questions. First, can one identify ligand binding sites without information on any 
potential ligand? Second, can we find the particular structure in the ensemble in which 
	  	  
75 
the shape of the pocket is the most similar to the one in the ligand-bound structure? 
Third, does ligand binding reduce the variability in the protein structure? Fourth, do the 
differences among the NMR structures represent real conformational changes, or are 
simply the results of the structure not being fully determined by the NOE constraints 
available from the NMR experiments? As we will show, the detailed analysis of NMR 
structures for five proteins that participate in protein-protein interactions and also bind 
small ligands or peptides can answer all four questions positively.  
As the primary tool of our analysis, we rely on the FTMap computational solvent 
mapping algorithm, which is a direct computational analog of the fragment screening 
experiments (Brenke, et al., 2009). FTMap places molecular probes the size of organic 
solvents on a dense grid around the protein, finds favorable positions using an empirical 
energy function, and identifies the hot spots as clusters of residues that have a large 
number of interactions with the probe molecules (Brenke, et al., 2009). Thus, selecting 
the hot spot regions is primarily based on the energy of interaction rather than on the 
geometry of the site. Although the relative importance of hot spots is affected by the 
conformational differences among the members of the NMR ensemble, we will show that 
the binding site residues still can be identified without any assumption on the particular 
ligand that binds to the site. In addition, we show that the structures in which the main 
binding sites bind the highest number of probe molecules are also the most similar ones 
to some ligand-bound structure, suggesting that the propensity of a site for binding small 
non-specific probes is highly correlated with the propensity of the same site for binding 
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specific ligands. Since computational solvent mapping enables the identification of such 
structures, the result has practical implications for ligand design.  
 
5.2 Results 
5.2.1 Conformational ensembles obtained by NMR 
We have studied the five proteins listed in Table 5.1, with structures available in the 
Protein Data Bank (PDB) (Berman, et al., 2000). The table also includes some of the 
results that will be described later in the paper. The structures of these proteins have been 
determined by nuclear magnetic resonance (NMR) in the ligand-free state, resulting in 
conformational ensembles, and also in complexes with peptides or small molecular 
inhibitors (see Methods). The bound structures have been obtained either by X-ray 
crystallography or NMR. For each protein the ligand-free structures in the NMR 
ensemble show substantial conformational variation, both in terms of the overall RMSD 
and in the binding site.  For each protein, ligand binding reduces the structural variation. 
 	    
	  	  
77 
Table 5.1 Protein targets and summary of results 
Protein-Protein Complex 
Receptor / Ligand 
Structures in PDB Model with highest 
BSSCc  Rd Unbounda Bound (Ligand)b 
MDM2 / p53 1z1m (24)  
1ycr (p53 
peptide) Model 19 (2
nd) 0.78 
1rv1 (Nutlin-2) Model 19 (2nd) 0.72 
2lzg 
(piperidinone) Model 9 (1
st) 0.77 
PSD-95 PDZ1 / CRIPT 1iu2 (50) 1rgr (peptide) Model 23 (1st) 0.92 
MAGI-1 PDZ1 / 
HPV16 E6 2kpk (20) 2kpl (peptide) Model 9 (3
rd) 0.77 
EDC3 / DCP2 4a53 (20) 4a54 (peptide) Model 16 (2nd) 0.60 
Bcl-xL / BAK, BAX, PUMA, 
BAD, etc.  2m03 (20) 
2yxj (ABT-737) 
 
Model 3 (1st) 
 
0.85 
1bxl (BAK 
peptide) Model 3 (1
st) 0.72 
a The number in parenthesis indicates the number of structures in the NMR ensemble. 
b In parenthesis we indicate the ligand bound to the protein. 
c BSSC denotes the bound-state similarity coefficient, which measures the similarity of each 
  model to the bound state. The number of parenthesis is the rank based on the binding site hit  
  rate (see Results). 
d R denotes the correlation coefficient between the binding site hit rate and BSSC. 
 
5.2.2 Identification of binding sites 	  
Residues with any atom closer than 4 Å to any atom of the ligand in the bound structure 
were defined as binding site residues. Although for the five test proteins in Table 5.1 
these residues are known, we explored whether the binding site can be found using only 
the ensemble of ligand-free structures, i.e., without any assumption on the ligand. We 
have previously developed the FTSite algorithm and server for the identification of 
binding sites on unbound protein structures (Ngan, et al., 2012). FTSite is based on 
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FTMap (Brenke, et al., 2009), and was capable of identifying binding sites in X-ray 
structures for over 94% of ligand-free proteins in two test sets (Ngan, et al., 2012) (see 
Methods). However, the structures in the NMR derived ensembles of ligand-free proteins 
substantially differ from each other, which leads to variations in the binding sites 
predicted by FTSite. Nevertheless, selecting the site that is the top ranked prediction in 
the highest number of structures correctly identifies the ligand binding site for four of the 
five proteins in Table 5.1 (see Figure 5.1). The only exception is Bcl-xL.  Mapping the 
NMR ensemble of ligand-free structures (PDB ID 2m03), the interaction site with the 
BAK peptide occurs as the top ranked binding site in only 6 of the 20 structures, and a 
different site is ranked first in the highest number of times (in 9 of the 20 structures).  
Although this second site is distinct from the canonical Bcl-xL binding groove, it was 
shown to be a highly functional peptide binding site in the BAX protein, a close 
homologue of Bcl-xL (see PDB ID 2k7w) (Gavathiotis, et al., 2008). In addition to 
determining the location of the main ligand binding sites, we can also use the FTSite 
results to find the binding site residues by selecting the residues that interact with probes 
a substantial number of structures of the ensemble (see Methods). 
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Figure 5.1 Identification of binding sites. A. Ligand-free MDM2 (1z1m, green) with p53 peptide (cyan) from the 
bound structure (1ycr). The top binding site predicted by FTSite (brown mesh) overlaps with the peptide in 18 of the 24 
structures of 1z1m. B. Ligand-free Bcl-xL structure (2m03, green), with BAK peptide (cyan) from structure 1bxl, 
inhibitor ABT-737 (red sticks) from structure 2yxj, and the BIH SAHB peptide (magenta) binding to the close Bcl-xL 
homologue BAX (2k7w). The top predicted binding site (brown mesh) overlaps with the BAK peptide and ABT-737 in 
6 of the 20 structures in 2m03, and with the BIH SAHB site in 9 of the 20 structures. C. Ligand-free EDC3 (4a53, 
green) with DCP2 peptide (cyan) from the structure 4a54. The top predicted binding site (brown mesh) overlaps with 
the peptide in all 20 structures in 4a53. D. Ligand-free MAGI1 PDZ1 (2kpk, green) with a C-terminal peptide of 
HPV16 E6 (cyan) from structure 2kpl. The top predicted binding site (brown mesh) overlaps with the peptide in 19 of 
the 20 structures in 2kpk. E. Ligand-free PSD-95 PDZ1 (1iu2, green) with a peptide (cyan) from structure 1rgr. The top 
predicted binding site (brown mesh) overlaps with the peptide in 40 of the 50 structures in 1iu2). 	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5.2.3 Binding site hit rate and bound state similarity coefficient 	  
As discussed, the residues in the binding site are likely to interact with probes in many 
structures. This is shown in Figure 5.2 for the 24 structures in the NMR ensemble of the 
ligand-free MDM2 (PDB ID 1z1m). For a more quantitative characterization of this 
relationship we introduce the concept of mapping fingerprint, defined as the number of 
probe-protein interactions for each residue, divided by the total number of interactions for 
all residues. For ligand-bound structures we also define the ligand fingerprint, which is 
the number of ligand-protein interactions for each residue, divided by the total number of 
interactions for all residues. If the bound structure is an NMR ensemble, we calculate the 
average ligand fingerprint (see Methods). For a protein of n residues, both the mapping 
and ligand fingerprints are n-vectors (see an example in Figure 5.3). We define the 
bound-state similarity coefficient (BSSC) as the correlation coefficient between the 
mapping fingerprint of a ligand-free structure and the ligand fingerprint of a bound 
structure. As will be shown, the structural variations in the ligand-free NMR ensembles 
cause substantial variations in BSSC, which can have values as high as 0.84 and as low as 
-0.09.  
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Figure 5.2 Mapping fingerprints of 24 unbound MDM2 structures. In each plot, horizontal axis, MDM2 residues 
(E25-Y104); vertical axis, percentage of probe-residue contacts (0-20%). Residues within 4 Å from the p53 peptide 
(PDB 1ycr) are marked with red dots. 
	  
Figure 5.3 Mapping fingerprints of MDM2 from unbound model 9 (blue), in comparison to ligand fingerprint 
calculated from a piperidinone-bound structure (red). Horizontal axes list residues of MDM2 from Glu25 to TYR104 
(unstructured regions removed before mapping a 
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One of the main questions considered here is how to identify, without information on any 
ligand, the particular ligand-free structure in the NMR ensemble that is most similar to a 
ligand bound state in terms of BSSC. Our hypothesis is that the key predictor of this 
similarity is the binding site hit rate (HR), defined as the sum of probe-protein 
interactions for all binding site residues (apart from lysines and arginines in the binding 
site) divided by the total number of probe-protein interactions. The hypothesis assumes 
that well-formed pockets that are capable of binding specific ligands (e.g., peptides or 
small molecular inhibitors) also tend to bind a large number of probe molecules, and thus 
the level of non-specific binding is a predictor of specific binding ability. The mapping 
results support this hypothesis, and show that structures with the highest hit rates tend to 
be similar to some ligand-bound structure. The reason of not accounting for lysine and 
arginine residues when calculating the binding site hit rate is that the positions of these 
side chains and hence their interactions with the probes are generally not very well 
defined, resulting in high level of uncertainty.  
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Figure 5.4 Binding site hit rates (blue columns, left axis) and BSSC (bound-state similarity coefficient) values 
(red lines, right axis) for the MDM2 ensemble (PDB ID 1z1m, 24 models). Horizontal axes list model numbers, with 
the last column showing the averaged binding site hit rate and BSSC value. BSSC values are defined for three different 
ligand-bound structures of MDM2. A. MDM2 bound to a p53 peptide (PDB ID 1ycr). B. MDM2 bound to the inhibitor 
Nutlin-2 (PDB ID 1rv1). C. MDM2 bound to a piperidinone derivative (PDB ID 2lzg). 
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Figure 5.4 shows the relationship between the binding site HR and BSSC for 24 NMR 
structures of ligand-free MDM2. The BSSC values are calculated for three different 
MDM2 structures bound to high affinity ligands, two of them small inhibitors and the 
third a peptide. The hit rates and BSSCs are also listed in Table 5.2. According to these 
results, model 9, which has the highest hit rate (0.78), also has the highest BSSC (0.84), 
the latter being based on the average ligand fingerprint of the NMR structure of MDM2 
bound to a piperidinone inhibitor, PDB ID 2lzg (Michelsen, et al., 2012). Model 19, 
which has the second highest hit rate (0.77), has the highest BSSC for two ligand-bound 
MDM2 structures, the first co-crystallized with a p53 peptide (Kussie, et al., 1996), and 
the second with the inhibitor Nutlin-2 (Vassilev, et al., 2004). Figure 5.5 and Tables 5.3 
through 5.5 show that the results are similar for PSD-95 PDZ1, MAGI-1 PDZ1, and 
EDC3. For PSD-95 PDZ1, model 23 has the highest hit rate, and this model is also the 
most similar to the bound state defined by the X-ray structure of the PDZ1 domain co-
crystallized with a cyclic peptide (Table 5.3). For MAGI-1 PDZ1, model 9 with the third 
highest hit rate (0.79) is the most similar to the peptide-bound structure 2kpl (Table 5.4). 
Models 7 and 17 have slightly higher hit rates, and are also fairly similar to the bound 
structure. Although at this point we have no ligand-bound structures with high level of 
similarity to these two models, their high hit rate implies that they have well-formed 
pockets, and thus it is likely that ligands binding to these conformations can be found. 
For EDC3 the model most similar to the peptide bound state is model 16, which has the 
second highest hit rate (0.97), but the highest hit rate is not much different (0.98) (Table 
5.5). Finally, according to the results for Bcl-xL, model 3 of the ensemble has the highest 
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hit rate, and it is most similar to both structures bound to the inhibitor ABT-737 and a 
BAK peptide (Figure 5.6 and Table 5.6).  
 
Table 5.2 Binding site hit rates (HRs) and bound state similarity coefficients (BSSCs) for the ensemble of ligand-
free MDM2 structures (PDB ID 1zlm). The BSSC values are calculated using the three ligand-bound structures 
with PDB IDs shown. The models are sorted based on the hit rate. The maximum value in each column is shown 
in bold. 
Model	   	  	  	  HR	  
	  	  	  BSSC	  
1ycr	   1rv1	   2lzg	  
9	   0.78	   0.53	   0.67	   0.84	  
19	   0.77	   0.65	   0.71	   0.71	  
10	   0.76	   0.47	   0.34	   0.41	  
4	   0.70	   0.51	   0.61	   0.61	  
11	   0.64	   0.42	   0.19	   0.53	  
6	   0.62	   0.54	   0.66	   0.58	  
8	   0.61	   0.41	   0.36	   0.49	  
5	   0.60	   0.48	   0.58	   0.66	  
21	   0.59	   0.59	   0.69	   0.57	  
22	   0.59	   0.33	   0.24	   0.40	  
16	   0.55	   0.38	   0.34	   0.59	  
23	   0.54	   0.50	   0.49	   0.60	  
Average	   0.54	   0.48	   0.44	   0.60	  
14	   0.53	   0.30	   0.39	   0.45	  
15	   0.51	   0.37	   0.53	   0.43	  
1	   0.47	   0.40	   0.17	   0.50	  
13	   0.47	   0.37	   0.22	   0.49	  
17	   0.47	   0.27	   0.12	   0.39	  
20	   0.45	   0.40	   0.24	   0.42	  
12	   0.44	   0.45	   0.31	   0.33	  
3	   0.43	   0.23	   0.19	   0.43	  
2	   0.41	   0.44	   0.29	   0.42	  
18	   0.36	   0.11	   0.10	   0.36	  
24	   0.34	   0.22	   0.21	   0.34	  
7	   0.29	   0.10	   0.04	   0.19	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Figure 5.5 Binding site hit rates (blue columns, left axis) and BSSC (bound-state similarity coefficient) values 
(red lines, right axis) for the ligand-free NMR structures of PSD-95 PDZ1, MAGI-1 PDZ1, and EDC3. 
Horizontal axes list model numbers, with the last column showing the averaged binding site hit rate and BSSC value. 
A. Unbound PSD-95 PDZ1 ensemble (PDB ID 1iu2, 50 models). BSSC values are defined for a peptide-bound 
structure (PDB ID 1rgr). B. Unbound MAGI-1 PDZ1 ensemble (PDB ID 2kpk, 20 models). BSSC values are defined 
for a peptide-bound structure (PDB ID 2kpl). C. Unbound EDC3 ensemble (PDB ID 4a53, 20 models). BSSC values 
are defined for a peptide-bound structure (PDB ID 4a54). 	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Table 5.3 Binding site hit rates and bound state similarity coefficients (BSSCs) for the ensemble of ligand-free  
PSD-95 PDZ1 structures (PDB ID 1iu2). The BSSC values are calculated using the ligand-bound structure with 
PDB IDs 1rgr. The models are sorted based on the hit rate. The maximum value in each column is shown in 
bold.  
Model	   HR	  
	  	  
BSSC	  
23	   0.58	   0.69	  
45	   0.48	   0.50	  
29	   0.45	   0.63	  
24	   0.38	   0.42	  
25	   0.38	   0.51	  
38	   0.35	   0.37	  
39	   0.34	   0.41	  
3	   0.32	   0.16	  
19	   0.32	   0.37	  
35	   0.32	   0.42	  
14	   0.31	   0.37	  
33	   0.3	   0.32	  
11	   0.29	   0.35	  
42	   0.29	   0.41	  
44	   0.29	   0.34	  
50	   0.29	   0.34	  
4	   0.27	   0.33	  
7	   0.27	   0.3	  
17	   0.27	   0.27	  
46	   0.27	   0.26	  
13	   0.25	   0.34	  
26	   0.25	   0.26	  
1	   0.24	   0.33	  
2	   0.24	   0.4	  
Average	   0.24	   0.33	  
6	   0.23	   0.31	  
10	   0.23	   0.29	  
31	   0.23	   0.27	  
22	   0.22	   0.23	  
43	   0.22	   0.21	  
48	   0.22	   0.35	  
47	   0.2	   0.25	  
16	   0.19	   0.17	  
27	   0.19	   0.16	  
49	   0.19	   0.18	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34	   0.18	   0.15	  
20	   0.17	   0.14	  
30	   0.17	   0.13	  
41	   0.17	   0.13	  
15	   0.16	   0.09	  
32	   0.16	   0.15	  
5	   0.15	   0.14	  
9	   0.15	   0.1	  
36	   0.15	   0.16	  
28	   0.14	   0.08	  
40	   0.14	   0.11	  
8	   0.12	   0.14	  
18	   0.12	   0.01	  
21	   0.12	   0.05	  
37	   0.11	   0.06	  
12	   0.08	   -­‐0.02	  
 
Table 5.4 Binding site hit rates and bound state similarity coefficients (BSSCs) for the ensemble of ligand-free  
MAGI-1 PDZ1 structures (PDB ID 1kpk). The BSSC values are calculated using the ligand-bound structure 
with PDB IDs 2kpl. The models are sorted based on the hit rate. The maximum value in each column is shown in 
bold.  
Model	   HR	   	  	  BSSC	  
7	   0.81	   0.52	  
17	   0.81	   0.50	  
9	   0.79	   0.58	  
13	   0.78	   0.52	  
6	   0.74	   0.51	  
5	   0.68	   0.48	  
2	   0.66	   0.51	  
18	   0.66	   0.50	  
4	   0.63	   0.49	  
10	   0.63	   0.54	  
Average	   0.63	   0.50	  
8	   0.59	   0.47	  
1	   0.58	   0.44	  
12	   0.58	   0.44	  
20	   0.58	   0.47	  
11	   0.57	   0.45	  
3	   0.54	   0.41	  
14	   0.53	   0.34	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15	   0.50	   0.28	  
16	   0.50	   0.42	  
19	   0.45	   0.40	  
 
Table 5.5 Binding site hit rates and bound state similarity coefficients (BSSCs) for the ensemble of ligand-free  
EDC3 structures (PDB ID 4a53). The BSSC values are calculated using the ligand-bound structure with PDB 
IDs 4a54. The models are sorted based on the hit rate. The maximum value in each column is shown in bold. 
	  	  	  
Model	   	  	  HR	   	  	  BSSC	  
18	   0.98	   0.50	  
16	   0.97	   0.60	  
5	   0.96	   0.53	  
11	   0.92	   0.53	  
8	   0.87	   0.43	  
12	   0.87	   0.50	  
19	   0.87	   0.56	  
9	   0.86	   0.50	  
13	   0.86	   0.44	  
14	   0.86	   0.52	  
Average	   0.85	   0.51	  
17	   0.84	   0.48	  
4	   0.83	   0.51	  
15	   0.83	   0.51	  
6	   0.82	   0.50	  
10	   0.82	   0.52	  
20	   0.82	   0.48	  
1	   0.80	   0.51	  
2	   0.80	   0.50	  
3	   0.79	   0.48	  
7	   0.72	   0.29	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Figure 5.6 Binding site hit rates (blue columns, left axis) and BSSC (bound-state similarity coefficient) values 
(red lines, right axis) for the Bcl-xL ensemble (PDB ID 2m03, 20 models). Horizontal axes list model numbers, with 
the last column showing the averaged binding site hit rate and BSSC value. BSSC values are defined for three different 
ligand-bound structures of MDM2. A. MDM2 bound to the inhibitor ABT-737 (PDB ID 2yxj). B. MDM2 bound to a 
BAK peptide (PDB ID 1bxl). 	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Table 5.6 Binding site hit rates and bound state similarity coefficients (BSSCs) for the ensemble of ligand-free 
Bcl-xL structures (PDB ID 2m03). The BSSC values are calculated using the two ligand-bound structures with 
PDB IDs shown in the table. The models are sorted based on the hit rate. The maximum value in each column is 
shown in bold. 
	  	  	  
Model	   	  	  HR	  
	  	  	  	  	  BSSC	  
	  	  	  	  	  	  	  
2yxj	   1bxl	  
3	   0.64	   0.52	   0.42	  
17	   0.58	   0.29	   0.12	  
16	   0.45	   0.11	   0.15	  
20	   0.45	   0.38	   0.14	  
1	   0.41	   0.21	   0.06	  
4	   0.38	   0.00	   0.00	  
8	   0.33	   0.14	   0.13	  
12	   0.33	   0.20	   0.10	  
14	   0.33	   0.08	   -­‐0.04	  
Average	   0.28	   0.16	   0.09	  
7	   0.25	   0.00	   0.06	  
11	   0.24	   0.13	   0.03	  
6	   0.23	   0.13	   0.11	  
18	   0.21	   0.06	   0.04	  
5	   0.20	   -­‐0.01	   -­‐0.05	  
19	   0.18	   -­‐0.01	   -­‐0.02	  
10	   0.13	   -­‐0.07	   -­‐0.09	  
13	   0.11	   -­‐0.07	   -­‐0.04	  
15	   0.09	   0.05	   0.10	  
9	   0.08	   -­‐0.03	   0.00	  
2	   0.02	   -­‐0.06	   -­‐0.03	  
 
So far we have shown that some of the ligand-free models with high binding site hit rates 
tend to be similar to known bound structures. To further explore the relationship between 
hit rate and BSSC values, we note that, for an ensemble of k structures, both measures are 
given as k-vectors, and thus we can calculate their correlation coefficient. These 
correlation coefficients, listed in Table 5.1 and also shown in Figures 5.4, 5.5 and 5.6, are 
surprisingly large, between 0.60 and 0.92, indicating that the binding site hit rate can be 
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used for the identification of structures that are likely to be the most similar to a ligand-
bound state. This relationship is clearly very important if no ligand-bound structure of a 
protein is available, and hence one has to select the ligand-free structure that will be used 
for structure based ligand design.  
 
5.3 Discussion 
The mechanistic models of protein–ligand interactions evolved from the early lock-and-
key hypothesis to the induced-fit model and to the model of conformational selection 
(Ma, Kumar, Tsai and Nussinov, 1999, Tsai, Ma and Nussinov, 1999, Boehr, Nussinov 
and Wright, 2009, Tsai, Ma, Sham, Kumar and Nussinov, 2001, Zhou, 2010, Csermely, 
Palotai and Nussinov, 2010, Wlodarski and Zagrovic, 2009, Vertessy and Orosz, 2011, 
Changeux and Edelstein, 2011, Straub, 1964), the latter based on the concept of 
“fluctuation fit” (Straub, 1964). The basic assumptions of the conformational selection 
model are that proteins sample a vast ensemble of conformational states (Straub, 1964) 
and that potentially higher energy conformations may be responsible for recognizing and 
binding to partners, with subsequent population shift toward these conformers (Boehr, 
Nussinov and Wright, 2009). This model challenges the assumption that conformational 
differences between free and ligand-bound proteins implicate an induced-fit mechanism 
of recognition. Distinguishing between the two mechanisms is far from easy, particularly 
because many recognition processes involve both (Boehr, Nussinov and Wright, 2009, 
Zhou, 2010, Csermely, Palotai and Nussinov, 2010, Wlodarski and Zagrovic, 2009). 
Structural evidence for conformational selection would entail the characterization of 
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alternative conformations in the free state that resemble the final ligand-bound 
conformation, and this would need to be complemented by studies demonstrating that 
ligands interact with a population of bound-like sub states. Thus, it follows that for any 
analysis of the recognition mechanisms it is necessary to obtain an ensemble of 
conformations and a measure that enables assessing the similarity between free and 
bound states.  
Ensembles of structures have been generated by a variety of computational and 
experimental tools. The computational method contributing the most to our 
understanding of molecular recognition processes is molecular dynamics (MD) 
(McCammon, Gelin and Karplus, 1977). However, modeling protein flexibility on the 
timescales of biological significance using MD remains a challenge (Meireles, Gur, 
Bakan and Bahar, 2011). As alternatives, coarse-grained analysis tools such as elastic 
network models (ENMs) can be used to predict collective motions of proteins (Meireles, 
Gur, Bakan and Bahar, 2011, Tobi and Bahar, 2005, Yang, Song and Jernigan, 2007).  
On the experimental side, X-ray crystallography rarely yields variety of conformations 
(Boehr, Nussinov and Wright, 2009). As shown in this paper, however, nuclear magnetic 
resonance (NMR) spectroscopy can be a very useful tool for obtaining ensembles of 
conformations (Boehr, Nussinov and Wright, 2009, Boehr, Dyson and Wright, 2006, 
Fenwick, Esteban-Martin and Salvatella, 2011), although here we restrict consideration to 
structure and do not discuss the variety of powerful NMR relaxation techniques that also 
provide information on the dynamics of transitions (Boehr, Dyson and Wright, 2006).  
Once ensembles of free and bound conformations are available, the second problem is 
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finding an appropriate measure of structural similarity. The overall root mean square 
deviation (RMSD) is clearly not suitable, since we are interested only in the regions of 
ligand binding. While one can calculate RMSD for the binding site residues, the latter are 
generally selected on the basis of their proximity to a bound ligand, which makes the 
results specific to a particular compound. The unique contribution of this paper is the 
unbiased characterization of the binding site on the basis of mapping, thus without 
assuming any specific ligand. The mapping fingerprint can be compared to various ligand 
fingerprints, each defined for a structure bound to a specific ligand. The high correlation 
coefficients between mapping and ligand fingerprints show that the NMR derived models 
of unliganded proteins deposited in the Protein Data Bank include structures that are 
similar to some ligand-bound structure.  
Our findings are in agreement with the conformational selection model, but also provide 
additional insight. While classical conformational selection assumes that proteins sample 
a vast conformational space (Ma, Kumar, Tsai and Nussinov, 1999, Tsai, Ma and 
Nussinov, 1999, Boehr, Nussinov and Wright, 2009, Vertessy and Orosz, 2011), the 20 to 
50 structures in the NMR ensembles deposited in the Protein Data Bank (Berman, et al., 
2000) are only tiny samples. Similarly, the sampling of bound states is minimal, since the 
peptides from the partner proteins and the small molecular inhibitors in the ligand-bound 
structures represent only a very small fraction of potential interactions. Thus, considering 
how small these samples are, it was somewhat unexpected to see that the ligand-free 
NMR ensembles always include some structures that are, in terms of residue contacts, 
very similar to some ligand-bound structures. Thus, the protein-protein interfaces 
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considered here have high tendency to form pockets that bind both fragment-sized probes 
in non-specific manner, as well as specific ligands. This outcome is in good agreement 
with a number of previous results, including the detailed analysis of ubiquitin dynamics 
by Lange et al. (Lange, et al., 2008), the recent simulations by Johnson and Karanicolas 
(Johnson and Karanicolas, 2013), and the large scale studies of binding pockets by Gao 
and Skolnick (Gao and Skolnick, 2013, Skolnick and Gao, 2013). In particular, the latter 
analysis shows that the biophysics of proteins, mainly their secondary structure, leads to 
the formation of broad specificity pockets with crude features, whereas additional smaller 
conformational changes may respond to details of a particular ligand (Skolnick and Gao, 
2013). In a similar vein, we have previously found that the druggable sites at PPIs are not 
simply sites that are complementary to particular organic functionality, but rather possess 
a general tendency to bind organic compounds with a variety of structures, including key 
side chains of the partner protein (Kozakov, et al., 2011).  
The second important observation made in this paper is that the ligand-free structures in 
the NMR ensemble with the highest level of similarity to a ligand-bound structure also 
have high hit rates, i.e., they interact with a large number of small molecules used as 
probes for the mapping. Both the structures and their putative ligand-binding sites can be 
easily identified by computational solvent mapping. Since these are the conformations 
that are most suitable for ligand design, the observation has clear practical significance. 
The third observation relates to the essential properties of NMR conformational 
ensembles. Strictly speaking, the structures in such ensembles are low energy models that 
satisfy the highest number of distance restraints due to nuclear Overhauser effects 
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(NOEs), and thus do not necessarily represent true fluctuations in the conformational 
space (Andrec, et al., 2007). In fact, it was reported that X-ray and NMR structures of the 
same protein have substantial differences (Andrec, et al., 2007, Garbuzynskiy, Melnik, 
Lobanov, Finkelstein and Galzitskaya, 2005, Wagner, Hyberts and Havel, 1992). Our 
results indicate that, in spite of the structural variations and deviations from X-ray 
structures, NMR is an important tool for determining protein structures that can be very 
useful for ligand design.  
 
5.4 Methods 
5.4.1 Selection of protein targets 	  
We briefly describe the motivation for selecting the targets listed in Table 5.1, as well as 
the structural information used for each protein.  
MDM2. The human version of the mouse double minute protein 2 (MDM2) is an 
important drug target for its role in binding and negatively regulating the tumor 
suppressor p53 (Uhrinova, et al., 2005). We take the only available ligand-free structure 
of MDM2, which is an NMR derived ensemble of 24 models (Uhrinova, et al., 2005), 
and consider its residues 25-104. The distribution of NOEs and relaxation parameters 
confirmed that a significant portion of the domain is poorly structured. MDM2 structures 
have also been determined for complexes with a p53 peptide (Kussie, et al., 1996) and 
several small molecular inhibitors (Michelsen, et al., 2012, Vassilev, et al., 2004). These 
structures show that the two sub-domains of the protein must move apart in order to make 
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place for ligands. 
PDZ1 domain of PSD-95. The three PDZ domains of the postsynaptic density protein 95 
(PSD-95) regulate signaling in glutaminergic neurons by modulating protein-protein 
interactions (Long, et al., 2003). The solution structure of the PDZ1 domain has been 
determined using NMR (Long, et al., 2003), and the 50 lowest energy models have been 
deposited in the PDB. In most of these structures, the binding cleft is shallow and 
nondescript, consistent with the transient interactions aimed to bring proteins together to 
facilitate signaling, and then rapidly disperse. The structure of the PDZ1 domain has also 
been determined in a complex with a peptide designed for improved binding (Piserchio, 
et al., 2004), resulting in better defined binding site and reduced structural variation.  
PDZ1 domain of MAGI-1. The PDZ domains of membrane-associated guanylate kinase 
with inverted domains 1 (MAGI-1) interact with the E6 proteins of human 
papillomaviruses (HPVs) (Charbonnier, et al., 2011). The solution structure of the 
MAGI-1 PDZ1 domain has been determined using NMR alone and bound to a peptide 
derived from the C-terminus of HPV16 E6 (Charbonnier, et al., 2011). The comparison 
of these structures shows that the binding of the peptide induces quenching of high-
frequency motions in the C-terminal tail of the PDZ domain.  
LSm domain of yeast EDC3. The like-SM (LSm) domain of the enhancer of decapping 3 
(EDC3) activator protein modulates the activity of the DCP1:DCP2 decapping complex, 
which catalyzes the removal of the mRNA 5’ cap (Fromm, et al., 2012). The structure of 
the yeast EDC3 LSm domain has been determined using NMR both alone and in complex 
with a short helical leucine-rich motif of DCP2. Fromm et al. (Fromm, et al., 2012) 
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deposited the 20 lowest energy structures for both the ligand-bound and ligand-free 
proteins.  
B-cell lymphoma-extra large (Bcl-xL). In several tissues, DNA damage induces apoptosis 
via the stabilization of p53. Bcl-xL is an antiapoptotic protein, which sequester p53 
(Follis, et al., 2013), is overexpressed in many cancers, and thus has been pursued as a 
target for drug discovery. The structure of Bcl-xL has been determined ligand-free 
(Follis, et al., 2013) and in complex with a variety of bound peptides and small molecule 
inhibitors (Sattler, et al., 1997, Lee, et al., 2007). 
 
5.4.2 Modifications of the FTMap and FTSite programs 	  
The main tools of our analysis are the FTMap and FTSite programs. Both programs place 
small molecules as probes on the protein surface to determine consensus clusters that 
bind clusters of different probes. The ranking of consensus clusters is based on the 
number of probe clusters in FTMap, and on the number of non-bonded interactions 
between the protein and all probes in FTSite.  Both FTMap and FTSite have been 
described previously (Brenke, et al., 2009, Ngan, et al., 2012). However, for this paper 
we introduced some changes in both algorithms, primarily to increase the computational 
speed. First, in the scoring function for the grid search, we use the simplified generalized 
Born (GB) type electrostatic term developed for the PIPER program (Kozakov, Brenke, 
Comeau and Vajda, 2006), rather than a Poisson-Boltzmann model. Second, we do not 
perform off-grid local energy minimization, thereby reducing the computational efforts 
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by almost an order of magnitude. All other details of the algorithms remain unchanged 
(Brenke, et al., 2009, Ngan, et al., 2012). 
 
5.4.3 Selection of binding site residues 	  
Using the FTSite results (Ngan, et al., 2012), for each residue we count the number of 
structures in which any atom of the residue is within 4 Å of the top prediction of the 
binding site, and rank the residues based on these counts. The selection of binding site 
residues starts with the top ranked residue, and we continue adding residues until a 15% 
or more drop occurs in the count. We used a slightly different algorithm for Bcl-xL: the 
residues were ranked based on the number of structures in which they were found within 
4 Å to any of the top three predicted binding sites, and added residues from this ranked 
list until a 50% drop in the count occurred. Although the cutoff rules introduced here may 
be specific to the proteins studied, it is general that the binding site residues are the ones 
that are close to the predicted binding sites in many structures of the NMR ensemble. 
 
Table 5.7 Validity of averaging fingerprints over bound structures solved by NMR. Pairwise correlation 
coefficients between the fingerprints for models 1-5 and the average fingerprint of the 5 ligand-bound MDM2 
structures (PDB ID 2lzg). 
Model	   Model	  2	   Model	  3	   Model	  4	   Model	  5	   Average	  
1	   0.794	   0.91	   0.84	   0.963	   0.954	  
2	  
	  
0.874	   0.897	   0.804	   0.922	  
3	  
	   	  
0.857	   0.876	   0.953	  
4	  
	   	   	  
0.86	   0.943	  
5	  
	   	   	   	  
0.954	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Table 5.8 Validity of averaging fingerprints over bound structures solved by NMR. Correlation coefficients 
between each fingerprint for models 1-22 and the average fingerprint of the 22 peptide-bound PSD-95 PDZ1 
structures (PDB ID 1rgr). 
Model	   Correlation	  
Model	  1	   0.991	  
Model	  2	   0.989	  
Model	  3	   0.983	  
Model	  4	   0.988	  
Model	  5	   0.984	  
Model	  6	   0.982	  
Model	  7	   0.971	  
Model	  8	   0.988	  
Model	  9	   0.989	  
Model	  10	   0.993	  
Model	  11	   0.966	  
Model	  12	   0.976	  
Model	  13	   0.992	  
Model	  14	   0.989	  
Model	  15	   0.973	  
Model	  16	   0.978	  
Model	  17	   0.971	  
Model	  18	   0.98	  
Model	  19	   0.982	  
Model	  20	   0.975	  
Model	  21	   0.982	  
Model	  22	   0.992	  
 
Table 5.9 Validity of averaging fingerprints over bound structures solved by NMR. Correlation coefficients 
between each fingerprint for models 1-20 and the average fingerprint from the ensemble of the 20 peptide-
bound MAGI-1 PDZ1 structures (PDB ID 2kpl). 
Model	   Correlation	  
Model	  1	   0.915	  
Model	  2	   0.757	  
Model	  3	   0.881	  
Model	  4	   0.861	  
Model	  5	   0.888	  
Model	  6	   0.899	  
Model	  7	   0.891	  
Model	  8	   0.872	  
Model	  9	   0.931	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Model	  10	   0.907	  
Model	  11	   0.909	  
Model	  12	   0.885	  
Model	  13	   0.895	  
Model	  14	   0.932	  
Model	  15	   0.928	  
Model	  16	   0.856	  
Model	  17	   0.934	  
Model	  18	   0.921	  
Model	  19	   0.873	  
Model	  20	   0.902	  
 
Table 5.10 Validity of averaging fingerprints over bound structures solved by NMR. Correlation coefficients 
between the fingerprint for models 1-22 and the average fingerprint from the ensemble of the 22 peptide-bound 
EDC3 structures (PDB ID 4a54). 
	  Model	   Correlation	  
Model	  1	   0.981	  
Model	  2	   0.984	  
Model	  3	   0.893	  
Model	  4	   0.897	  
Model	  5	   0.908	  
Model	  6	   0.971	  
Model	  7	   0.86	  
Model	  8	   0.979	  
Model	  9	   0.951	  
Model	  10	   0.994	  
Model	  11	   0.9	  
Model	  12	   0.925	  
Model	  13	   0.949	  
Model	  14	   0.967	  
Model	  15	   0.971	  
Model	  16	   0.948	  
Model	  17	   0.954	  
Model	  18	   0.944	  
Model	  19	   0.965	  
Model	  20	   0.986	  
Model	  21	   0.843	  
Model	  22	   0.962	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5.4.4 Calculation of the bound state similarity coefficient (BSSC) 	  
BSSC for a ligand-free structure is the correlation coefficient between the mapping 
fingerprint, defined as the number of probe-protein interactions for each residue divided 
by the total number of interactions, and the ligand fingerprint of a bound structure, which 
is the number of ligand-protein interactions for each residue divided by the total number 
of interactions. If the bound structure is an NMR ensemble, BSSC is based on the 
average ligand fingerprint. As shown by the Tables 5.7 through 5.10, the ligand 
fingerprints are very similar within ensembles of such ligand-bound structures, and hence 
the average fingerprint is a valid measure of interactions.  
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